<SEC-DOCUMENT>0000950157-21-000681.txt : 20210622
<SEC-HEADER>0000950157-21-000681.hdr.sgml : 20210622
<ACCEPTANCE-DATETIME>20210622161003
ACCESSION NUMBER:		0000950157-21-000681
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210621
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210622
DATE AS OF CHANGE:		20210622

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MARTIN MARIETTA MATERIALS INC
		CENTRAL INDEX KEY:			0000916076
		STANDARD INDUSTRIAL CLASSIFICATION:	MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400]
		IRS NUMBER:				561848578
		STATE OF INCORPORATION:			NC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12744
		FILM NUMBER:		211035315

	BUSINESS ADDRESS:	
		STREET 1:		2710 WYCLIFF ROAD
		CITY:			RALEIGH
		STATE:			NC
		ZIP:			27607
		BUSINESS PHONE:		919-781-4550

	MAIL ADDRESS:	
		STREET 1:		2710 WYCLIFF ROAD
		CITY:			RALEIGH
		STATE:			NC
		ZIP:			27607
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:mlm="http://martinmarietta.com/20210621" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Cravath, Swaine & Moore LLP
         Document created using EDGARfilings PROfile 7.5.0.0
         Copyright 1995 - 2021 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_a5a6f7f313f74a7781882fd35c312f73" contextRef="c20210621to20210621" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_e8f5621b6ff54d96ab7c123ad8272a21" contextRef="c20210621to20210621">0000916076</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="mlm-20210621.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20210621to20210621"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000916076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-21</xbrli:startDate><xbrli:endDate>2021-06-21</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><br />
  </div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

  <div>
    <div><br />
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">UNITED STATES</div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>

    <div><br />
    </div>

    <div>
      <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div><br />
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_b655bc540e404adeb186ba793d7f976a" contextRef="c20210621to20210621">8-K</ix:nonNumeric></div>

    <div><br />
    </div>

    <div>
      <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div><br />
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PURSUANT TO SECTION 13 OR 15(d)</div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OF THE SECURITIES EXCHANGE ACT OF 1934</div>

    <div><br />
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_ae78e677515143f8987189a45557814e" contextRef="c20210621to20210621" format="ixt:datemonthdayyearen">June 21, 2021</ix:nonNumeric></div>

    <div><br />
    </div>

    <div>
      <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div><br />
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-style: normal; font-variant: normal; text-transform: uppercase;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_4c70cb0d6304471783f50bf01b8db12a" contextRef="c20210621to20210621">Martin Marietta Materials, Inc.</ix:nonNumeric></span><br />
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>

    <div><br />
    </div>

    <div>
      <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z75aaa600070142799741b8f6ea0c4a97">


  <tr>

    <td style="width: 33.74%; vertical-align: middle;">&#160;</td>

    <td style="width: 1.38%; vertical-align: bottom;">&#160;</td>

    <td style="width: 31.75%; vertical-align: middle;">&#160;</td>

    <td style="width: 1.38%; vertical-align: bottom;">&#160;</td>

    <td style="width: 31.75%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33.74%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_ec44c07b11a04d8baf2c7c01effc55da" contextRef="c20210621to20210621" format="ixt-sec:stateprovnameen">North Carolina</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 1.38%; vertical-align: bottom;">&#160;</td>

    <td style="width: 31.75%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_865f1523ca2b4bc1bb0fefe975f71edd" contextRef="c20210621to20210621">1-12744</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 1.38%; vertical-align: bottom;">&#160;</td>

    <td style="width: 31.75%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_64dfb24c845343ec8a1596f590fa171f" contextRef="c20210621to20210621">56-1848578</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 33.74%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 8pt; font-weight: bold;">(State or Other Jurisdiction<span style="font-size: 8pt; font-family: 'Times New Roman';"><br />
              </span>of Incorporation)</div>
          </td>

    <td style="width: 1.38%; vertical-align: bottom;">&#160;</td>

    <td style="width: 31.75%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 8pt; font-weight: bold;">(Commission<span style="font-size: 8pt; font-family: 'Times New Roman';"><br />
              </span>File Number)</div>
          </td>

    <td style="width: 1.38%; vertical-align: bottom;">&#160;</td>

    <td style="width: 31.75%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 8pt; font-weight: bold;">(IRS Employer<span style="font-size: 8pt; font-family: 'Times New Roman';"><br />
              </span>Identification No.)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf2d52f8cd46a459891d5c67d0ce132b9">


  <tr>

    <td style="width: 50.33%; vertical-align: middle;">&#160;</td>

    <td style="width: 1.38%; vertical-align: bottom;">&#160;</td>

    <td style="width: 48.29%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50.33%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_032cbe1b472542449731c32179994a71" contextRef="c20210621to20210621">4123 Parklane Avenue</ix:nonNumeric>,
              <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_a287e99ca14d45b29187f8e3a0128938" contextRef="c20210621to20210621">Raleigh</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_71b076190ca24305b343d820827c61f9" contextRef="c20210621to20210621" format="ixt-sec:stateprovnameen">North Carolina</ix:nonNumeric></div>
          </td>

    <td style="width: 1.38%; vertical-align: bottom;">&#160;</td>

    <td style="width: 48.29%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_37dd35238db344ab90c03d1570152d4b" contextRef="c20210621to20210621">27612</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 50.33%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 8pt; font-weight: bold;">(Address of principal executive offices)</div>
          </td>

    <td style="width: 1.38%; vertical-align: bottom;">&#160;</td>

    <td style="width: 48.29%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 8pt; font-weight: bold;">(Zip Code)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_6de7c025612e49bea7962868495c7122" contextRef="c20210621to20210621">919</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_9cd53bdcc7994dd9aee0f8a321d4adc4" contextRef="c20210621to20210621">781-4550</ix:nonNumeric></div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 8pt; font-weight: bold;">(Registrant&#8217;s telephone number, including area code)</div>

    <div><br />
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Not Applicable</div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 8pt; font-weight: bold;">(Former name or former address, if changed since last report)</div>

    <div><br />
    </div>

    <div>
      <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
      (see General Instruction A.2. below):</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4aee6ecf2b514e48ad9d36c435557746">


  <tr>

    <td style="width: 3.69%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Segoe UI Symbol',sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_3625bd4c2b43405fa9fbaa928afcf7e6" contextRef="c20210621to20210621" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 96.31%; vertical-align: middle; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 3.69%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_6ec78d9c0eda494ca600bcbb38c87011" contextRef="c20210621to20210621" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 96.31%; vertical-align: middle; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 3.69%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_13c3650191594f2b866f1174b84412c0" contextRef="c20210621to20210621" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 96.31%; vertical-align: middle; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
          </td>

  </tr>

  <tr>

    <td style="width: 3.69%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Segoe UI Symbol',sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_0e44f75ec66442579ce354f91c7f71b1" contextRef="c20210621to20210621" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 96.31%; vertical-align: middle; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z984cb1be4593422d95cdc176eaa66a14">


  <tr>

    <td style="width: 33.33%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt; font-weight: bold;">Title of each class</div>
            </div>
          </td>

    <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt; font-weight: bold;">Trading Symbol(s)</div>
            </div>
          </td>

    <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td style="width: 33.32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt; font-weight: bold;">Name of each exchange<span style="font-size: 8pt; font-family: 'Times New Roman';"><br />
                </span>on which registered</div>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 33.33%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_f499cc222b144d729d40669849330a69" contextRef="c20210621to20210621">Common Stock, $.01 par value</ix:nonNumeric><br />
            </div>
          </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 32%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_07359535fd6844b6b9b184ddedcf1a4b" contextRef="c20210621to20210621">MLM</ix:nonNumeric><br />
            </div>
          </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 33.32%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_958f6384db5745318da8826c013216a5" contextRef="c20210621to20210621" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric><br />
            </div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">&#167;</span> 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">&#167;</span> 240.12b-2 of this chapter).</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_21a6beb7c435490094cbc99833200a9b" contextRef="c20210621to20210621" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-size: 10pt; font-family: 'Segoe UI Symbol', sans-serif; color: #000000;">&#9744;</span></div>

    <br />
    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="page-break-after:always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;" /></div>

    </div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;"> <br />
      </span></div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">Item 1.01.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">Entry into a Material Definitive Agreement.</span></div>

    <div><br />
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the issuance of $700 million aggregate principal amount of 0.650% Senior Notes due 2023 (the &#8220;2023 Notes&#8221;), $900 million aggregate
      principal amount of 2.400% Senior Notes due 2031 (the &#8220;2031 Notes&#8221;) and $900 million aggregate principal amount of 3.200% Senior Notes due 2051 (the &#8220;2051 Notes&#8221; and, together with the 2023 Notes and the 2031 Notes, the &#8220;Notes&#8221;) on June 21, 2021,
      Martin Marietta Materials, Inc. (&#8220;Martin Marietta&#8221; or the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;), with Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Truist Securities, Inc. and Wells Fargo
      Securities, LLC, as representatives of the several underwriters named therein (the &#8220;Underwriters&#8221;), pursuant to which the Underwriters agreed to purchase the Notes from the Company.&#160; The Underwriting Agreement contains the terms and conditions of the
      offering and sale of the Notes, indemnification and contribution obligations and other customary terms and conditions.</div>

    <div><br />
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of
      the Underwriting Agreement, which is attached hereto as Exhibit 1.1 and incorporated by reference herein.</div>

    <div><br />
    </div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">Item 7.01.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">Regulation FD Disclosure.</span></div>

    <div><br />
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In accordance with General Instruction B.2. of Form 8-K, the following information and the attached Exhibit 99.1 shall not be deemed to be &#8220;filed&#8221; for
      purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.&#160; Martin Marietta disclaims any intention or obligation to update
      or revise this information.</div>

    <div><br />
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Attached as Exhibit 99.1, and incorporated herein by reference, is a copy of Martin Marietta&#8217;s press release dated June 21, 2021, announcing the pricing
      of the Notes.</div>

    <div><br />
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This current report does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of the Notes in any
      jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.</div>

    <div><br />
    </div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Item 9.01.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Financial Statements and
        Exhibits.</span></div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z824a3b4ac6a44e3ab285c73f7d940977">


  <tr>

    <td colspan="2" style="vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d) Exhibit No.</div>
          </td>

    <td style="width: 88%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: right;"><a href="ex1-1.htm">1.1</a></div>
          </td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 88%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="ex1-1.htm">Underwriting Agreement, dated as of June 21,
                2021, between Martin Marietta Materials, Inc. and Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.</a></div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: right;"><a href="ex99-1.htm">99.1</a></div>
          </td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 88%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="ex99-1.htm">Press release announcing pricing terms of debt
                offering dated June 21, 2021.</a></div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; text-align: right;" rowspan="1">104 </td>

    <td style="width: 5%; vertical-align: top; text-align: right;" rowspan="1">&#160;</td>

    <td style="width: 88%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1">
            <div>Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="page-break-after:always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;" /></div>

    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

    <div><br />
    </div>

    <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its
      behalf by the undersigned hereunto duly authorized.</div>

    <div><br />
    </div>

    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr>

    <td valign="top" style="width: 50%;">&#160;</td>

    <td valign="top" colspan="3" style="font-weight: bold;">MARTIN MARIETTA MATERIALS, INC.</td>

    <td valign="top" style="width: 12%;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" style="width: 50%;">&#160;</td>

    <td valign="top" style="width: 3%;">&#160;</td>

    <td valign="top" colspan="2">&#160;</td>

    <td valign="top" style="width: 12%;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;"><br />
            </td>

    <td valign="top" style="width: 3%; padding-bottom: 2px;">
              <div style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; text-align: left;">By: </div>
            </td>

    <td valign="top" align="left" colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">/s/ James A. J. Nickolas</td>

    <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" style="width: 50%;">&#160;</td>

    <td valign="top" style="width: 3%;">&#160;</td>

    <td valign="bottom" align="left" style="width: 4%; white-space: nowrap;">Name:</td>

    <td valign="bottom" align="left" style="width: 31%; white-space: nowrap;">James A. J. Nickolas</td>

    <td valign="top" style="width: 12%;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" style="width: 50%;">&#160;</td>

    <td valign="top" style="width: 3%;">&#160;</td>

    <td valign="top" style="width: 4%;">Title:</td>

    <td valign="top" style="width: 31%;">Senior Vice President and Chief Financial Officer</td>

    <td valign="top" style="width: 12%;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" style="width: 50%;">&#160;</td>

    <td valign="top" style="width: 3%;">&#160;</td>

    <td valign="top" colspan="2">&#160;</td>

    <td valign="top" style="width: 12%;">&#160;</td>

  </tr>


</table>
    </div>

    <div><br />
    </div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Date:&#160; June 22, 2021</div>

    <div><br />
    </div>

  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<DESCRIPTION>UNDERWRITING AGREEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Cravath, Swaine & Moore LLP
         Document created using EDGARfilings PROfile 7.5.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 1.1</font><br>
  </div>
  <div> <br>
  </div>
  <div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">EXECUTION VERSION</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">MARTIN MARIETTA MATERIALS, INC.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$700,000,000 0.650% SENIOR NOTES DUE 2023<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>$900,000,000 2.400% SENIOR NOTES DUE 2031<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>$900,000,000 3.200% SENIOR NOTES DUE 2051</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Underwriting Agreement</u></div>
    <div><br>
    </div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">June 21, 2021</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Deutsche Bank Securities Inc.<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>J.P. Morgan Securities LLC<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>Truist Securities, Inc.<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>Wells Fargo Securities, LLC</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">As Representatives of the<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>several Underwriters listed<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>in Schedule I hereto</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o Deutsche Bank Securities Inc.<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>60 Wall Street<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>New York, New York 10005</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o J.P. Morgan Securities LLC<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>383 Madison Avenue<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>New York, New York 10179</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o Truist Securities, Inc.<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>3333 Peachtree Road NE, 11<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>Atlanta, Georgia 30326</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o Wells Fargo Securities, LLC<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>550 South Tryon Street, 5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>Charlotte, North Carolina 28202</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ladies and Gentlemen:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Martin Marietta Materials, Inc., a North Carolina corporation (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Company</u></font>&#8221;),











      proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule&#160;I</u></font> hereto (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Underwriters</u></font>&#8221;) for whom Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC are acting as representatives (in such capacity, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Representatives</u></font>&#8221;) $700,000,000 aggregate principal amount of the Company&#8217;s 0.650% Senior Notes due 2023 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>2023











          Notes</u></font>&#8221;), $900,000,000 aggregate principal amount of the Company&#8217;s 2.400% Senior Notes due 2031 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>2031 Notes</u></font>&#8221;) and $900,000,000 aggregate principal amount
      of the Company&#8217;s 3.200% Senior Notes due 2051 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>2051 Notes</u></font>&#8221; and, together with the 2023 Notes and the 2031 Notes, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Securities</u></font>&#8221;), to be issued under an indenture, dated May 22, 2017 (together with a fourth supplemental indenture by and between the Company and Regions Bank, as trustee (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Trustee</u></font>&#8221;), dated the Time of Delivery (as defined in Section 2 hereof) establishing the terms of the Securities, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indenture</u></font>&#8221;),
      between the Company and the Trustee.</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The 2031 Notes and the 2051 Notes (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>SMR Notes</u></font>&#8221;) are being
      issued and sold in connection with the proposed acquisition (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Acquisition</u></font>&#8221;) of Lehigh Cement Company LLC, a Delaware limited liability company (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Lehigh Cement</u></font>&#8221;), HMBA Holdings LLC, a Delaware limited liability company (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>HMBA Holdings</u></font>&#8221;) and Lehigh Southwest Cement
      Company, a California Company (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Lehigh Southwest</u></font>&#8221; which, together with Lehigh Cement and HMBA Holdings and their respective consolidated subsidiaries, shall be referred to
      herein as the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Lehigh Entities</u></font>&#8221;) by the Company pursuant to a securities purchase agreement, dated as of May 23, 2021 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Purchase Agreement</u></font>&#8221;), by and among the Company, the Lehigh Entities and the other parties thereto. Subject to the terms of the Indenture, each of the SMR Notes will be redeemed (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Special Mandatory Redemption</u></font>&#8221;) at a price equal to 101% of the outstanding aggregate principal amount of such SMR Notes, plus accrued and unpaid interest on such SMR Notes to, but excluding, the date
      of the Special Mandatory Redemption, in the event that (i)&#160;the Acquisition is not consummated prior to March 31, 2022, (ii)&#160;the Purchase Agreement is terminated at any time prior to March 31, 2022 (other than as a result of consummating the
      Acquisition) or (iii)&#160;the Company publicly announces at any time prior to March 31, 2022 that it will no longer pursue the consummation of the Acquisition.</div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Representations,











            Warranties and Agreements of the Company</u></font>.&#160; The Company represents and warrants to, and agrees with, each of the Underwriters that:</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">An &#8220;automatic shelf registration statement&#8221; as defined under Rule 405 under
        the Securities Act of 1933, as amended (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Securities Act</u></font>&#8221;), on Form S-3 (File No. 333-238199) in respect of the Securities has been filed with the Securities and
        Exchange Commission (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Commission</u></font>&#8221;) not earlier than three years prior to the date of this Agreement; such registration statement, and any post-effective amendment
        thereto, became effective on filing; no stop order suspending the effectiveness of such registration statement or any part thereof has been issued and no proceeding for that purpose has been initiated or threatened by the Commission, and no notice
        of objection of the Commission to the use of such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company; the various parts of such registration statement,
        including all exhibits thereto (other than the Statement of Eligibility and Qualification on Form&#160;T&#8209;1) and including any prospectus supplement relating to the Securities that is filed with the Commission pursuant to Rule 424(b) under the Securities
        Act and deemed by Rule 430B under the Securities Act to be part of such registration statement, each as amended at the time such part of the registration statement became effective, are hereinafter collectively called the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Registration Statement</u></font>&#8221;; the base prospectus filed as part of the Registration Statement, in the form in which it was most recently filed with the Commission prior to or on the date of this
        Agreement, is hereinafter called the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Base Prospectus</u></font>&#8221;; the final prospectus supplement to such prospectus (including the Base Prospectus) relating to the Securities, in
        the form filed or to be filed with the Commission pursuant to Rule 424(b) under the Securities Act, is hereinafter called the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Prospectus</u></font>&#8221;; any preliminary prospectus
        (including any preliminary prospectus supplement) relating to the Securities, in the form filed or to be filed with the Commission pursuant to Rule 424(b), is hereinafter called a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Preliminary











            Prospectus</u></font>&#8221;; the Base Prospectus, as amended or supplemented immediately prior to the Applicable Time (as defined in Section 1(e) hereof), including, without limitation, any Preliminary Prospectus relating to the Securities, is
        hereinafter called the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Pricing Prospectus</u></font>&#8221;; any reference in this Agreement to the Registration Statement, the Base Prospectus, any Preliminary Prospectus, the Pricing
        Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein that were filed under the Securities Exchange Act of 1934, as amended (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exchange Act</u></font>&#8221;), or the Securities Act, as the case may be, and the rules and regulations of the Commission thereunder, on or before the date of this Agreement or the issue date of any such prospectus; any reference to
        &#8220;amend,&#8221; &#8220;amendment,&#8221; &#8220;supplement&#8221; or similar terms with respect to the Registration Statement, the Base Prospectus, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus shall be deemed to refer to and include any documents filed
        under the Exchange Act or the Securities Act, as the case may be, after the date of this Agreement or the issue date of any such prospectus which are deemed to be incorporated by reference therein; and any &#8220;issuer free writing prospectus&#8221; (as
        defined in Rule 433 under the Securities Act) relating to the Securities that (x) is required to be filed with the Commission by the Company or (y) is exempt from filing pursuant to Rule 433(d)(5)(i) under the Securities Act because it contains a
        description of the Securities or the offering that does not reflect the final terms is hereinafter called an &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Issuer Free Writing Prospectus</u></font>&#8221;;</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The documents incorporated by reference in the Registration Statement, the
        Pricing Prospectus and the Prospectus (including, without limitation, the interactive data in eXtensible Business Reporting Language (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>XBRL</u></font>&#8221;) included or incorporated by
        reference therein), when they were filed with the Commission or became effective, as the case may be, conformed in all material respects to the requirements of the Exchange Act or the Securities Act, as the case may be, and the rules and
        regulations of the Commission thereunder; none of such documents contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and any
        further documents so filed and incorporated by reference in the Registration Statement, the Pricing Prospectus and the Prospectus (including, without limitation, the interactive data in XBRL included or incorporated by reference therein), when such
        documents are filed with the Commission or become effective, as the case may be, will conform in all material respects to the requirements of the Exchange Act or the Securities Act, as applicable, and the rules and regulations of the Commission
        thereunder and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font>, that this representation and warranty shall not apply to any statements or omissions made therein in
        reliance upon and in conformity with information furnished in writing to the Company by any Underwriter through the Representatives expressly for use therein;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Registration Statement, any Preliminary Prospectus and the Pricing
        Prospectus conform, and the Prospectus and any post-effective amendments or supplements to the Registration Statement or the Prospectus will conform, in all material respects, to the requirements of the Securities Act and the Trust Indenture Act of
        1939, as amended (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Trust Indenture Act</u></font>&#8221;), and the rules and regulations of the Commission thereunder; and (i) the Registration Statement and any amendment thereto, as
        of their applicable effective dates relating to the Securities, did not and will not contain any untrue statement of material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not
        misleading, (ii) any Preliminary Prospectus, the Pricing Prospectus, the Prospectus and any amendment or supplement thereto, as of their issue dates, did not and will not contain any untrue statement of a material fact or omit to state a material
        fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading and (iii) the Prospectus and the Prospectus as amended or supplemented, if applicable, at the Time of Delivery (as
        defined in Section 2 hereof), will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font>, that this representation and warranty shall not
        apply to any statements or omissions made therein in reliance upon and in conformity with information furnished in writing to the Company by any Underwriter through the Representatives expressly for use therein;</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company has been, and continues to be, a &#8220;well-known seasoned issuer&#8221;
        (as defined in Rule 405 under the Securities Act), and has not been, and continues not to be, an &#8220;ineligible issuer&#8221; (as such term is defined in Rule 405 under the Securities Act), in each case as from the earliest time after the filing of the
        Registration Statement that the Company or another offering participant made a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">bona fide</font>&#8221; offer (within the meaning of Rule 164(h)(2) under the Securities
        Act) of the Securities;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">As used herein, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Pricing Disclosure Package</u></font>&#8221; means, collectively, (i) the Pricing Prospectus, (ii) the Pricing Term Sheet prepared and filed pursuant to Section 5(b) hereof and (iii) any other Issuer Free Writing Prospectus that is
        identified on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule II</u></font> hereto; and the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Applicable Time</u></font>&#8221; means 5:05 p.m. (New York City
        time) on the date of this Agreement.&#160; The Pricing Disclosure Package, as of the Applicable Time, did not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the
        light of the circumstances under which they were made, not misleading; and each Issuer Free Writing Prospectus identified on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule II</u></font> hereto does not conflict with the
        information contained in the Registration Statement, the Pricing Prospectus or the Prospectus; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>,<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"> however</font>, that this representation and warranty shall not apply to statements or omissions made therein in reliance upon and in conformity with information furnished in writing to the Company by any Underwriter
        through the Representatives expressly for use therein;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company has not made, and, without the prior written consent of the
        Representatives, will not make, any offer relating to the Securities that would constitute an &#8220;issuer free writing prospectus&#8221; (as defined in Rule 433 under the Securities Act) required to be filed by the Company with the Commission or retained by
        the Company pursuant to Rule 433 under the Securities Act; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>,<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">
          however</font>, that the prior written consent of the Representatives shall be deemed to have been given with respect to the Issuer Free Writing Prospectuses identified on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule











            II</u></font> hereto or used prior to the date hereof with the approval of the Representatives; and the Company has complied, and will comply, with the requirements of Rule 433 under the Securities Act applicable to any such Issuer Free Writing
        Prospectus, including in respect of timely filing with the Commission, legending and record-keeping;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company&#8217;s capitalization as of March 31, 2021 is as set forth in the
        &#8220;Actual&#8221; column of the table under the heading &#8220;Capitalization&#8221; in the Registration Statement, the Pricing Disclosure Package and the Prospectus.&#160; Subject to the assumptions and qualifications described under such heading, the &#8220;As Adjusted&#8221; column
        of such table fairly presents in all material respects the Company&#8217;s capitalization as of March 31, 2021 as adjusted in the manner described under the heading &#8220;Capitalization&#8221; in the Registration Statement, the Pricing Disclosure Package and the
        Prospectus. All of the outstanding shares of capital stock of the Company and shares of capital stock or other ownership interests of those subsidiaries of the Company that are &#8220;significant subsidiaries&#8221; within the meaning of Rule 405 under the
        Securities Act (each, a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Significant Subsidiary</u></font>&#8221;) have been, and at the Time of Delivery will be, duly authorized and validly issued and are fully paid and, with respect
        to shares of capital stock, non-assessable, and were not issued in violation of any preemptive or similar rights.&#160; As of the date hereof, all of the outstanding shares of capital stock or other ownership interests of each of the Significant
        Subsidiaries are, and at the Time of Delivery will be, free and clear of all liens, encumbrances, equities and claims or restrictions on transferability (other than those imposed by the Securities Act and the securities or &#8220;Blue Sky&#8221; laws of
        certain jurisdictions) or voting.&#160; Except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no (i)&#160;options, warrants or other rights to purchase, (ii) agreements or other obligations to issue
        or (iii)&#160;other rights to convert any obligation into, or exchange any securities for, shares of capital stock of the Company or shares of capital stock or other ownership interests of any of the Significant Subsidiaries outstanding;</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Each of the Company and its subsidiaries (i) has been duly incorporated or
        formed, is validly existing and in good standing (where such concept is recognized in the relevant jurisdiction) under the laws of its respective jurisdiction of incorporation or formation, (ii) has all requisite power and authority to own its
        properties and conduct its business as now conducted and as described in the Registration Statement, Pricing Disclosure Package and the Prospectus and (iii) is duly qualified to do business in all other jurisdictions where the ownership or leasing
        of its properties or the conduct of its business requires such qualification, except where the failure to satisfy any of the conditions of clause (i) with respect to the Company&#8217;s subsidiaries or clause (ii) or (iii) with respect to the Company or
        its subsidiaries would not, individually or in the aggregate, have a material adverse effect on the general affairs, management, business, financial position, results of operations or prospects of the Company and its subsidiaries taken as a whole
        or on the performance by the Company of its obligations under the Securities (any such event, a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Material Adverse Effect</u></font>&#8221;);</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company has all requisite corporate power and authority to execute,
        deliver and perform each of its obligations under the Securities.&#160; The Securities, when issued, will be in the form contemplated by the Indenture.&#160; The Securities have been duly and validly authorized by the Company and, when executed by the
        Company and authenticated by the Trustee in accordance with the provisions of the Indenture and when delivered to and paid for by the Underwriters in accordance with the terms of this Agreement, will constitute valid and legally binding obligations
        of the Company, entitled to the benefits of the Indenture, and enforceable against the Company in accordance with their terms, except that the enforcement thereof may be subject to (i)&#160;bankruptcy, insolvency, reorganization, moratorium or other
        similar laws now or hereafter in effect relating to creditors&#8217; rights generally and (ii)&#160;general principles of equity and the discretion of the court before which any proceeding therefor may be brought (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Enforceability Exceptions</u></font>&#8221;);</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company has all requisite corporate power and authority to execute,
        deliver and perform its obligations under the Indenture. The Indenture has been duly and validly authorized by the Company and duly qualified under the Trust Indenture Act, and, when executed and delivered by the Company (assuming the due
        authorization, execution and delivery by the Trustee) will constitute a valid and legally binding agreement of the Company, enforceable against the Company in accordance with its terms, except that the enforcement thereof may be subject to the
        Enforceability Exceptions;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company has all requisite corporate power and authority to execute,
        deliver and perform its obligations under this Agreement and to consummate the transactions contemplated hereby.&#160; This Agreement and the consummation by the Company of the transactions contemplated hereby have been duly and validly authorized by
        the Company.&#160; This Agreement has been duly executed and delivered by the Company;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(l)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Assuming the accuracy of and subject to compliance by the Underwriters with
        the representations and warranties set forth in Section 4 hereof, no consent, approval, authorization or order of any court or governmental agency or body, or third party is required for the issuance and sale by the Company of the Securities to the
        Underwriters or the consummation by the Company of the other transactions contemplated hereby, except for the registration of the Securities under the Securities Act, the qualification of the Indenture under the Trust Indenture Act and such
        consents, approvals, authorizations, orders and registrations or qualifications (x) as may be required under applicable state securities laws in connection with the purpose and distribution of the Securities by the Underwriters or (y) the failure
        of which to obtain, or the absence of which, would not, individually or in the aggregate, result in a Material Adverse Effect.&#160; None of the Company or its subsidiaries is (i) in violation of its certificate of incorporation or bylaws (or similar
        organizational document), (ii) in breach or violation of any statute, judgment, decree, order, rule or regulation applicable to any of them or any of their respective properties or assets or (iii) in breach of or default under (nor has any event
        occurred that, with notice or passage of time or both, would constitute a default under) or in violation of any of the terms or provisions of any indenture, mortgage, loan agreement or other agreement or instrument to which any of them is a party
        or to which any of them or their respective properties or assets is subject (collectively, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Contracts</u></font>&#8221;), except, in the case of clauses (ii) and (iii), for any such
        breach, default, violation or event that would not, individually or in the aggregate, have a Material Adverse Effect;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(m)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The execution, delivery and performance by the Company of this Agreement,
        the Indenture and the Securities and the consummation by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance and sale of the Securities to the Underwriters) will not conflict with or
        constitute or result in a breach of or a default under (or an event that with notice or passage of time or both would constitute a default under) or violation of any of (i) the terms or provisions of any Contract, except for any such conflict,
        breach, violation, default or event that would not, individually or in the aggregate, have a Material Adverse Effect, (ii) the certificate of incorporation or bylaws (or similar organizational document) of the Company or any of its Significant
        Subsidiaries or (iii) (assuming compliance with all applicable state securities or &#8220;Blue Sky&#8221; laws and assuming the accuracy of the representations and warranties of the Underwriters in Section 4 hereof) any statute, judgment, decree, order, rule
        or regulation applicable to the Company or any of its subsidiaries or any of their respective properties or assets, except for any such conflict, breach, violation, default or event that would not, individually or in the aggregate, have a Material
        Adverse Effect;</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(n)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The audited consolidated financial statements and the related notes thereto
        included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus comply in all material respects with the applicable requirements of the Securities Act and the Exchange Act, as applicable, and
        present fairly in all material respects the financial position, results of operations and cash flows of the Company and its subsidiaries at the dates and for the periods to which they relate and have been prepared in accordance with U.S. generally
        accepted accounting principles applied on a consistent basis, except as otherwise stated therein.&#160; The summary financial and statistical data in the Registration Statement, the Pricing Disclosure Package and the Prospectus present fairly in all
        material respects the information shown therein and have been prepared and compiled on a basis consistent with the audited financial statements included therein, except as otherwise stated therein.&#160; The interactive data in XBRL included or
        incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#8217;s rules and guidelines
        applicable thereto.&#160; PricewaterhouseCoopers LLP, who has certified certain financial statements of the Company and its subsidiaries, is an independent public accounting firm within the meaning of the Securities Act and the rules and regulations
        promulgated thereunder;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(o)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Except as described in the Registration Statement, the Pricing Disclosure
        Package and the Prospectus, there is not pending or, to the knowledge of the Company, threatened any action, suit, proceeding, inquiry or investigation to which the Company or any of its subsidiaries is a party, or to which the property or assets
        of the Company or any of its subsidiaries are subject, before or brought by any court, arbitrator or governmental agency or body, the adverse determination of which is reasonably likely to occur, and if so determined adversely to the Company or any
        of its subsidiaries, would, individually or in the aggregate, be reasonably likely to have a Material Adverse Effect or restrain, enjoin or prevent the consummation of the issuance or sale of the Securities to be sold hereunder or the consummation
        of the other transactions described in the Registration Statement, the Pricing Disclosure Package and the Prospectus;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(p)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Each of the Company and its subsidiaries possesses all licenses, permits,
        certificates, consents, orders, approvals and other authorizations from, and has made all declarations and filings with, all federal, state, local and other governmental authorities, all self-regulatory organizations and all courts and other
        tribunals, presently required or necessary to own or lease, as the case may be, and to operate its respective properties and to carry on its respective businesses as now or proposed to be conducted as set forth in the Registration Statement, the
        Pricing Disclosure Package and the Prospectus (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Permits</u></font>&#8221;), except where the failure to obtain such Permits would not, individually or in the aggregate, have a Material
        Adverse Effect.&#160; Each of the Company and its subsidiaries has fulfilled and performed all of its obligations with respect to such Permits and no event has occurred that allows, or after notice or lapse of time would allow, revocation or termination
        thereof or results in any other material impairment of the rights of the holder of any such Permit, except where any such failure or event would not, individually or in the aggregate, have a Material Adverse Effect.&#160; None of the Company or its
        subsidiaries has received any notice of any proceeding relating to revocation or modification of any such Permit, except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and except where such revocation
        or modification would not, individually or in the aggregate, have a Material Adverse Effect;</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(q)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Except as described in the Registration Statement, the Pricing Disclosure
        Package and the Prospectus, since the date of the most recent financial statements of the Company included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (i) none of the Company or its
        subsidiaries has incurred any liabilities or obligations, direct or contingent, or entered into or agreed to enter into any transactions or contracts (written or oral) not in the ordinary course of business, which liabilities, obligations,
        transactions or contracts would, individually or in the aggregate, be material to the general affairs, management, business, financial position, results of operations or prospects of the Company and its subsidiaries, taken as a whole, (ii) the
        Company has not purchased any of its outstanding capital stock, nor declared, paid or otherwise made any dividend or distribution of any kind on its capital stock and (iii) there has not been any change in the capital stock or long-term
        indebtedness of the Company or its subsidiaries;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(r)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Each of the Company and its subsidiaries has filed all necessary federal,
        state and foreign income and franchise tax returns, except where the failure to so file such returns would not, individually or in the aggregate, have a Material Adverse Effect, and has paid all taxes shown as due thereon.&#160; Other than tax
        deficiencies that the Company or any subsidiary is contesting in good faith and for which the Company or such subsidiary has provided adequate reserves, there is no tax deficiency that has been asserted against the Company or any of its
        subsidiaries that would, individually or in the aggregate, have a Material Adverse Effect;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(s)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The statistical and market-related data included or incorporated by
        reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus are based on or derived from sources that the Company and its subsidiaries believe to be reliable and accurate;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(t)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Except as would not, individually or in the aggregate, have a Material
        Adverse Effect, (i) the Company and its subsidiaries&#8217; information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications and databases (collectively, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>IT Systems</u></font>&#8221;) are adequate for, and operate and perform as required in connection with, the operation of the business of the Company and its subsidiaries as currently conducted, (ii)&#160;the Company and its
        subsidiaries have implemented and maintained commercially reasonable controls, policies, procedures and safeguards to maintain and protect their confidential information and the integrity, continuous operation, redundancy and security of all IT
        Systems and data (including all personal, personally identifiable, sensitive, confidential or regulated data (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Personal Data</u></font>&#8221;)) used in connection with their businesses,
        and except for any breaches, violations, outages or unauthorized uses of or accesses to IT Systems or Personal Data that have been remedied without material cost or liability or the duty to notify any other person, to the knowledge of the Company
        there have not been any breaches, violations, outages or unauthorized uses of or accesses to IT Systems or Personal Data, or any incidents under internal review or investigations relating to the same and (iii)&#160;the Company and its subsidiaries are
        presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy
        and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification.</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(u)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">None of the Company, its subsidiaries or any agent acting on their behalf
        has taken or will take any action that might cause this Agreement or the sale of the Securities to violate Regulation&#160;T, U or X of the Board of Governors of the Federal Reserve System, in each case as in effect, or as the same may hereafter be in
        effect, at the Time of Delivery;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Each of the Company and its subsidiaries has good and marketable title to
        all real property and good title to all personal property described in the Registration Statement, the Pricing Disclosure Package and the Prospectus as being owned by it and good and marketable title to a leasehold estate in the real and personal
        property described in the Registration Statement, the Pricing Disclosure Package and the Prospectus as being leased by it free and clear of all liens, charges, encumbrances or restrictions, except as described in the Registration Statement, the
        Pricing Disclosure Package and the Prospectus or to the extent the failure to have such title or the existence of such liens, charges, encumbrances or restrictions would not, individually or in the aggregate, have a Material Adverse Effect.&#160; The
        Company and its subsidiaries own or possess adequate licenses or other rights to use all patents, trademarks, service marks, trade names, copyrights and know-how necessary to conduct the businesses now or proposed to be operated by them in all
        material respects as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, and none of the Company or its subsidiaries has received any notice of infringement of or conflict with (or knows of any such
        infringement of or conflict with) asserted rights of others with respect to any patents, trademarks, service marks, trade names, copyrights or know-how that, if such assertion of infringement or conflict were sustained, would have a Material
        Adverse Effect;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(w)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Except as described in the Registration Statement, the Pricing Disclosure
        Package and the Prospectus or as would not, individually or in the aggregate, have a Material Adverse Effect, (A) each of the Company and its subsidiaries is in compliance with, and has not received any notice alleging liability under, applicable
        Environmental Laws (as defined below), (B) each of the Company and its subsidiaries has made all filings and provided all notices required under any applicable Environmental Law, and has obtained and is in compliance with, all Permits required
        under any applicable Environmental Laws and each of them is in full force and effect, (C) there is no civil, criminal or administrative action, suit, demand, claim, hearing, notice of violation, investigation, proceeding, notice or demand letter or
        request for information pending or, to the knowledge of the Company or any of its subsidiaries, threatened against the Company or any of its subsidiaries under any Environmental Law, (D) none of the Company or its subsidiaries has received notice
        that it has been identified as a potentially responsible party under the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>CERCLA</u></font>&#8221;),











        or any comparable state law and (E) no property or facility of the Company or any of its subsidiaries is (i) listed or, to the knowledge of the Company or any of its subsidiaries, proposed for listing on the National Priorities List under CERCLA or
        is (ii) listed in the Comprehensive Environmental Response, Compensation, Liability Information System List or Superfund Enterprise Management System promulgated pursuant to CERCLA, or on any comparable list maintained by any state or local
        governmental authority. For purposes of this Agreement, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Environmental Laws</u></font>&#8221; means the common law and all applicable federal, state and local laws or regulations, codes,
        orders, decrees, judgments or injunctions issued, promulgated, approved or entered thereunder, relating to pollution or protection of public or employee health and safety (as such relates to hazardous materials) or the environment, including,
        without limitation, laws relating to (i) emissions, discharges, releases or threatened releases of hazardous materials into the environment (including, without limitation, ambient air, surface water, ground water, land surface or subsurface
        strata), (ii) the manufacture, processing, distribution, use, generation, treatment, storage, disposal, transport or handling of hazardous materials and (iii)&#160;underground and above ground storage tanks and related piping, and emissions, discharges,
        releases or threatened releases of hazardous materials therefrom;</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(x)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">There is no strike, labor dispute or work stoppage with the employees of
        the Company or any of its subsidiaries that is pending or, to the knowledge of the Company or any of its subsidiaries, threatened that would, individually or in the aggregate, have a Material Adverse Effect;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(y)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company carries insurance in such amounts and covering such risks as is
        adequate for the conduct of its business and the value of its properties;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(z)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Except as would not, individually or in the aggregate, have a Material
        Adverse Effect, none of the Company or its subsidiaries has any liability for any prohibited transaction or funding deficiency or any complete or partial withdrawal liability with respect to any pension, profit sharing or other plan that is subject
        to the Employee Retirement Income Security Act of 1974, as amended (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ERISA</u></font>&#8221;), to which the Company or any of its subsidiaries makes or ever has made a contribution and in
        which any employee claiming a benefit through its employment with the Company or any of its subsidiaries is a participant.&#160; With respect to such plans, the Company and each subsidiary is in compliance in all material respects with all applicable
        provisions of ERISA;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(aa)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Each of the Company and its subsidiaries (i) makes and keeps accurate
        books and records and (ii) maintains internal accounting controls that provide reasonable assurance that (A)&#160;transactions are executed in accordance with management&#8217;s authorization, (B) transactions are recorded as necessary to permit preparation
        of its financial statements and to maintain accountability for its assets, (C) access to its assets is permitted only in accordance with management&#8217;s authorization and (D) the reported accountability for its assets is compared with existing assets
        at reasonable intervals.&#160; The Company and its subsidiaries maintain systems of &#8220;internal control over financial reporting&#8221; (as defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of the Exchange Act and have been
        designed by, or under the supervision of, management to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting
        principles;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(bb)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company and its subsidiaries maintain an effective system of
        &#8220;disclosure controls and procedures&#8221; (as defined in Rule&#160;13a-15(e) of the Exchange Act) that is designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded,
        processed, summarized and reported within the time periods specified in the Commission&#8217;s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company&#8217;s management as
        appropriate to allow timely decisions regarding required disclosure.&#160; The Company and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule&#160;13a-15 of the Exchange Act;</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(cc)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company is not, nor after receipt of the proceeds of the offering of
        the Securities and the application thereof as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will be, an &#8220;investment company&#8221; as such term is defined in the Investment Company Act of 1940, as amended, and
        the rules and regulations thereunder;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(dd)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Securities and the Indenture will, at the Time of Delivery, conform in
        all material respects to the descriptions thereof in the Registration Statement, the Pricing Disclosure Package and the Prospectus;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ee)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Immediately after the consummation of the transactions contemplated by
        this Agreement, the fair value and present fair saleable value of the assets of each of the Company and its subsidiaries (each on a consolidated basis) will exceed the sum of its stated liabilities and identified contingent liabilities; none of the
        Company or its subsidiaries (each on a consolidated basis) is, nor will any of the Company or its subsidiaries (each on a consolidated basis) be, after giving effect to the execution, delivery and performance of this Agreement, and the consummation
        of the transactions contemplated hereby, (a) left with unreasonably small capital with which to carry on its business as it is proposed to be conducted, (b) unable to pay its debts (contingent or otherwise) as they mature or (c) otherwise
        &#8220;insolvent&#8221; as such term is generally understood for purposes of applicable fraudulent transfer laws;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ff)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">None of the Company or its subsidiaries has taken, nor will any of them
        take, directly or indirectly, any action designed to, or that might be reasonably expected to, cause or result in any stabilization or manipulation of the price of the Securities;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(gg)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Neither the Company nor any of its subsidiaries nor, to the knowledge of
        the Company, any director, officer, agent, employee, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries has: (i) used any corporate funds for any unlawful contribution, gift, entertainment or
        other unlawful expense relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of the
        Foreign Corrupt Practices Act of 1977, as amended, or (to the extent applicable) any law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or (to the extent
        applicable) committed an offence under the Bribery Act 2010 of the United Kingdom, or any other applicable anti-bribery or anti-corruption laws; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful
        payment.&#160; The Company and its subsidiaries have instituted, maintained and enforced, and will continue to maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption
        laws.&#160; The Company will not directly or, to the knowledge of the Company, indirectly use the proceeds of the offering of the Securities, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other
        person or entity in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any applicable anti-bribery or anti-corruption law.</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(hh)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The operations of the Company and its subsidiaries are and have been
        conducted at all times in compliance in all material respects with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, and (to the extent applicable) the money
        laundering statutes of all jurisdictions in which the Company or its subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any
        governmental agency (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Money Laundering Laws</u></font>&#8221;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any
        arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Neither the Company nor any of its subsidiaries nor, to the knowledge of
        the Company, any director, officer, agent, employee, affiliate&#160; or other person associated with or acting on behalf of the Company or any of its subsidiaries is currently subject to any sanctions administered or enforced by the U.S. Government,
        (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State and including, without limitation, the designation as a &#8220;specially designated national&#8221; or &#8220;blocked
        person&#8221;), or (to the extent applicable) the United Nations Security Council, the European Union, Her Majesty&#8217;s Treasury or other relevant sanctions authority (collectively, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Sanctions</u></font>&#8221;),











        nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject or the target of Sanctions, including, without limitation, Crimea, Cuba, Iran, North Korea and Syria (each, a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Sanctioned Country</u></font>&#8221;); and the Company will not directly or indirectly use the proceeds of the offering of the Securities, or lend, contribute or otherwise make available such
        proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is the subject or the target of Sanctions, (ii)
        to fund or facilitate any activities of or business in any Sanctioned Country or (iii) to the knowledge of the Company, in any other manner that will result in a violation by any person participating in the transaction, whether as an underwriter,
        initial purchaser, advisor, investor or otherwise of Sanctions.&#160; For the past five years, the Company and its subsidiaries have not knowingly engaged in, are not now knowingly engaged in, and will not knowingly engage in, any dealings or
        transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country; and</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(jj)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Purchase Agreement has been duly authorized, executed and delivered by
        the Company and, assuming that the Purchase Agreement has been duly authorized, executed and delivered by the other parties thereto, constitutes a valid and legally binding agreement of the Company, enforceable against the Company in accordance
        with its terms, subject to the Enforceability Exceptions.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any certificate signed by any officer of the Company and delivered to the Representatives or counsel for the Underwriters pursuant to this Agreement
      shall be deemed a representation and warranty by the Company, as to matters covered thereby, to each Underwriter.</div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Purchase
            and Sale of Securities</u></font>.&#160; Subject to the terms and conditions herein set forth, the Company agrees to issue and sell to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the
        Company, the respective principal amount of Securities set forth opposite such Underwriter&#8217;s name in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule I</u></font> hereto at a price equal to 99.738% of the principal amount
        of the 2023 Notes, 99.287% of the principal amount of the 2031 Notes and 98.322% of the principal amount of the 2051 Notes, plus, in each case, accrued interest, if any, from July 2, 2021 to the Time of Delivery (as defined below).</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Securities to be purchased by each Underwriter hereunder will be delivered by or on behalf of the Company to the Representatives for the account of
      such Underwriter, against payment by such Underwriter or on its behalf of the purchase price therefor by wire transfer of federal (same-day) funds, at the office of Simpson Thacher &amp; Bartlett LLP, at 9:30 a.m. (New York City time) on July 2,
      2021, or at such other time and date (not later than the fifth business day thereafter) as the Representatives and the Company may agree upon in writing, such time and date being herein called the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Time of Delivery</u></font>&#8221;.&#160; The Securities will be delivered by the Company to the Representatives in the form of global Securities, representing all of the Securities, which will be deposited by the Representatives on behalf of
      the Underwriters with The Depository Trust Company, or its nominee, for credit to the respective accounts of the Underwriters.</div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Offer and
            Sale of Securities by the Underwriters</u></font>.&#160; Upon the authorization by the Representatives of the release of the Securities, the several Underwriters propose to offer the Securities for sale upon the terms and conditions set forth in the
        Registration Statement, the Pricing Disclosure Package and the Prospectus.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Representations,











            Warranties and Agreements of the Underwriters</u></font>.&#160; Each Underwriter, severally and not jointly, represents and warrants to, and agrees with, the Company and the Representatives that it has not made, and unless it obtains the prior
        written consent of the Company and the Representatives, it will not make, any offer relating to the Securities that would constitute an &#8220;issuer free writing prospectus&#8221; (as defined in Rule 433 under the Securities Act) or that would otherwise
        constitute a &#8220;free writing prospectus&#8221; (as defined in Rule 405 under the Securities Act) required to be filed with the Commission; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>,<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"> however</font>, that the prior written consent of the Company shall be deemed to have been given with respect to the Issuer Free Writing Prospectuses identified on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule II</u></font> hereto.&#160; The Company represents that it has treated or agrees that it will treat any such issuer free writing prospectus or free writing prospectus to which it so
        consents as an Issuer Free Writing Prospectus, and has complied and will comply with the requirements of Rule 433 applicable thereto, including with respect to timely filing with the Commission, legending and record-keeping.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Further
            Agreements of the Company</u></font>.&#160; The Company agrees with each of the Underwriters:</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To prepare the Prospectus in a form reasonably approved by the
        Representatives and to file the Prospectus pursuant to Rule 424(b) under the Securities Act no later than the Commission&#8217;s close of business on the second business day following the date of this Agreement or, if applicable, such earlier time as may
        be required by Rule 424(b); and to make no further amendment or supplement to the Registration Statement, the Pricing Prospectus or the Prospectus after the date of this Agreement and prior to the Time of Delivery which shall be reasonably
        disapproved by the Representatives promptly after reasonable notice thereof unless in the opinion of counsel for the Company such amendment or supplement is required by law; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>,<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"> however</font>, that in the case of any periodic filing to be filed by the Company with the Commission pursuant to Section 13(a) or 15(d)
        of the Exchange Act during such period, the Company shall furnish to the Representatives a draft of any such filing for review by the Representatives prior to filing with the Commission and shall discuss any reasonable comments that the
        Representatives may have with respect to such draft prior to filing;</font></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To prepare a pricing term sheet (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Pricing Term Sheet</u></font>&#8221;) reflecting the final terms of the Securities, in the form previously agreed upon by the Company and the Underwriters, and to file such Pricing Term Sheet as an &#8220;issuer free
        writing prospectus&#8221; pursuant to Rule 433 under the Securities Act prior to the close of business two business days after the date of this Agreement; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>,<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"> however</font>, that the Company shall furnish the Representatives with copies of the Pricing Term Sheet prior to such proposed filing and shall not use or file any
        such document which shall be disapproved by the Representatives; and to file promptly any other Issuer Free Writing Prospectus or other material required to be filed by the Company with the Commission pursuant to Rule 433 under the Securities Act
        in accordance with Section 1(f) hereof;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To file promptly all reports and any definitive proxy or information
        statements required to be filed by the Company with the Commission pursuant to Section&#160;13(a) or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus (or in lieu thereof, the notice
        referred to in Rule 173(a) under the Securities Act) is required in connection with the offering or sale of the Securities (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>prospectus delivery period</u></font>&#8221;); and, during
        the prospectus delivery period, to advise the Representatives, promptly after it receives notice thereof, of (i) the time when any post-effective amendment to the Registration Statement has been filed or becomes effective or any amendment or
        supplement to the Prospectus or any amended Prospectus has been filed with the Commission (<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font> that no such notification need be given in connection with
        any such amendment or supplement consisting of a document filed by the Company with the Commission pursuant to Section 13(a) or 15(d) of the Exchange Act subsequent to the Time of Delivery unless the Representatives have advised the Company that
        the Underwriters have not completed the distribution of the Securities), (ii) the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, of any order suspending or preventing the use of any
        prospectus relating to the Securities or any Issuer Free Writing Prospectus, or of any notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the
        Securities Act, (iii) the suspension of the qualification of the Securities for offering or sale in any jurisdiction, (iv) the initiation or threatening of any proceeding for the purpose of any of the foregoing or (v) any request by the Commission
        for the amending or supplementing of the Registration Statement or of the Prospectus or for additional information; and, in the event of the issuance of any such stop order or any such order preventing or suspending the use of any Preliminary
        Prospectus or other prospectus relating to the Securities or any Issuer Free Writing Prospectus or suspending any such qualification, or of any such notice of objection pursuant to Rule 401(g)(2) under the Securities Act, to use promptly its
        reasonable best efforts to obtain the withdrawal of such order; and, in the event of any such issuance of a notice of objection, promptly to take such steps including, without limitation, amending the Registration Statement or filing a new
        registration statement, at its own expense, as may be necessary to permit offers and sales of the Securities by the Underwriters (references herein to the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Registration Statement</u></font>&#8221;
        shall include any such amendment or new registration statement);</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To take such action as the Representatives may reasonably request to
        qualify the Securities for offer and sale under the securities laws of such jurisdictions as the Representatives may request and to comply with such laws so as to permit the continuance of sales and dealings therein in such jurisdictions for as
        long as may be necessary to complete the distribution or sale of the Securities; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font>, that in connection therewith the Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process in any jurisdiction;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To furnish each Underwriter with one copy of the Registration Statement
        and, during the prospectus delivery period referred to in Section&#160;5(c) hereof, to furnish the Underwriters with copies of the Pricing Disclosure Package and the Prospectus in New York City in such quantities as the Representatives may reasonably
        request (excluding, in each case, any documents incorporated by reference therein to the extent available through the Commission&#8217;s EDGAR system);</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">If, during the prospectus delivery period referred to in Section 5(c)
        hereof, any event shall have occurred as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in
        the light of the circumstances under which they were made when such Prospectus is delivered, not misleading or, if for any other reason it shall be necessary in the opinion of counsel for the Company during such prospectus delivery period to amend
        or supplement the Prospectus or to file with the Commission any document incorporated by reference in the Prospectus in order to comply with the Securities Act, the Exchange Act or the Trust Indenture Act, to notify the Representatives and prepare
        and file such document and to furnish without charge to each Underwriter as many copies as the Representatives may from time to time reasonably request of an amended Prospectus or a supplement to the Prospectus which will correct such statement or
        omission or effect such compliance;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To make generally available to its securityholders as soon as practicable,
        but in any event not later than 18 months after the effective date of the Registration Statement (as defined in Rule 158(c) under the Securities Act), an earning statement of the Company and its subsidiaries (which need not be audited) complying
        with Section&#160;11(a) of the Securities Act (including, at the option of the Company, Rule 158);</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">[reserved]</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To pay the Commission the required filing fees relating to the Securities
        within the time period required by Rule 456(b)(1) under the Securities Act;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">During the period beginning from the date hereof and continuing to and
        including the earlier of the Time of Delivery and such earlier time as you may notify the Company, not to offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise transfer or dispose of, directly or
        indirectly, or file with the Commission a registration statement under the Securities Act relating to, except as provided hereunder, any securities of the Company that are substantially similar to the Securities, or publicly disclose the intention
        to make any such offer, sale, pledge, disposition or filing without the prior written consent of the Representatives; and</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company will not take, directly or indirectly, any action designed to
        or that would constitute or that might reasonably be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Payment of
            Expenses</u></font>.&#160; The Company covenants and agrees with the several Underwriters that the Company will pay or cause to be paid the following:&#160; (i)&#160;the fees, disbursements and expenses of counsel for the Company and the Company&#8217;s independent
        registered public accounting firm in connection with the registration of the Securities under the Securities Act and all other expenses in connection with the preparation, printing and filing of the Registration Statement, the Base Prospectus, any
        Preliminary Prospectus, the Pricing Prospectus and the Prospectus and amendments and supplements thereto, and any Issuer Free Writing Prospectus, and the mailing and delivering of copies thereof to the Underwriters and dealers and any out-of-pocket
        costs associated with electronic delivery of any of the foregoing by the Underwriters to investors; (ii) all expenses in connection with the qualification of the Securities for offer and sale under state securities laws as provided in Section&#160;5(d)
        hereof, including the reasonable fees and disbursements of counsel for the Underwriters in connection with such qualification and in connection with the Blue Sky and legal investment memoranda; (iii)&#160;all expenses and application fees incurred in
        connection with any filing with, and clearance of the offering by, the Financial Industry Regulatory Authority, Inc., if any, including the reasonable fees and disbursements of counsel for the Underwriters thereto; (iv) any fees charged by
        securities rating services for rating the Securities; (v)&#160;the cost of preparing the Securities; (vi)&#160;the fees and expenses of the Trustee and any agent of the Trustee and the reasonable fees and disbursements of counsel for the Trustee and any such
        agent in connection with the Indenture and the Securities; (vii) all other costs and expenses incident to the performance of the Company&#8217;s obligations hereunder which are not otherwise specifically provided for in this Section 6; and (viii) all
        expenses incurred by the Company in connection with any &#8220;roadshow&#8221; presentation to potential investors, if any.&#160; It is understood, however, that, except as provided in this Section 6 and Sections 8 and 11 hereof, the Underwriters will pay all of
        their own costs and expenses, including any transfer taxes on resale of any of the Securities by them, and any advertising expenses incurred in connection with any offers they may make.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Conditions
            of Underwriters&#8217; Obligations</u></font>.&#160; The obligations of the Underwriters hereunder shall be subject, in the discretion of the Representatives, to (i) the condition that all representations and warranties of the Company herein are as of the
        Time of Delivery true and correct, (ii) the condition that the Company shall have performed all of its obligations hereunder theretofore to be performed and (iii) the following additional conditions:</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Any Preliminary Prospectus and the Prospectus shall have been filed with
        the Commission pursuant to Rule 424(b) under the Securities Act within the applicable time period prescribed for each such filing by the rules and regulations under the Securities Act and in accordance with Section 5(a) hereof; and the Pricing Term
        Sheet provided for in Section 5(b) hereof and any other Issuer Free Writing Prospectus relating to the Securities shall have been filed with the Commission pursuant to Rule 433 under the Securities Act within the applicable time period prescribed
        for such filing by Rule 433 and in accordance with Section 5(b) hereof (unless such Issuer Free Writing Prospectus is not required to be filed with the Commission pursuant to Rule 433(d)(5)(i));</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">No stop order suspending the effectiveness of the Registration Statement or
        any part thereof or suspending or preventing the use of the Prospectus or any Issuer Free Writing Prospectus shall have been issued, and no proceeding for that purpose shall have been initiated or threatened by the Commission, and no notice of
        objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act shall have been received;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Cravath, Swaine &amp; Moore LLP, counsel for the Company, shall have
        furnished to the Representatives their written opinion and negative assurance letter, dated the Time of Delivery, in form and substance substantially in the form set forth in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule











            III</u></font> hereto;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Robinson, Bradshaw &amp; Hinson, P.A., North Carolina counsel for the
        Company, shall have furnished to the Representatives their written opinion, dated the Time of Delivery, in form and substance substantially in the form set forth in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule IV</u></font>
        hereto;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Simpson Thacher &amp; Bartlett LLP, counsel for the Underwriters, shall
        have furnished to the Representatives their written opinion and negative assurance letter, dated the Time of Delivery, with respect to the validity of the Indenture and the Securities, the Registration Statement, the Pricing Disclosure Package, the
        Prospectus, and other related matters as the Representatives may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon such matters;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">On the date of this Agreement and at the Time of Delivery,
        PricewaterhouseCoopers LLP, which has audited the financial statements of the Company and its subsidiaries as of and for the periods ended December 31, 2018, December 31, 2019 and December 31, 2020 included or incorporated by reference in the
        Registration Statement, the Pricing Disclosure Package and the Prospectus, shall have furnished to the Representatives a &#8220;comfort&#8221; letter or letters, dated the date of this Agreement and Time of Delivery, respectively, as to such matters as the
        Representatives may reasonably request and in form and substance reasonably satisfactory to the Representatives (which comfort letter or letters shall, as applicable, be substantially consistent with drafts provided by PricewaterhouseCoopers LLP to
        the Representatives prior to or on the date of this Agreement);</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Since the respective dates as of which information is given in the
        Registration Statement, the Pricing Disclosure Package and the Prospectus, there shall not have been a material adverse change in the business, financial condition, prospects or results of operations of the Company and its subsidiaries, taken as a
        whole, otherwise than as set forth or contemplated in the Pricing Disclosure Package and the Prospectus (excluding any amendment or supplement thereto), the effect of which is in the judgment of the Representatives so material and adverse as to
        make it impracticable or inadvisable to proceed with the public offering, sale or the delivery of the Securities on the terms and in the manner contemplated in the Pricing Disclosure Package and the Prospectus;</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">On or after the date of this Agreement there shall not have occurred any of
        the following:&#160; (i)&#160;a suspension or material limitation in trading in securities generally on The New York Stock Exchange or the NASDAQ Global Market; (ii) a suspension or material limitation in trading of any securities issued by the Company;
        (iii)&#160;a general moratorium on commercial banking activities declared by either Federal or New York State authorities; (iv)&#160;the outbreak or escalation of hostilities involving the United States or the declaration by the United States of a national
        emergency or war; or (v)&#160;the occurrence of any other calamity or crisis affecting the financial markets of the United&#160;States, if the effect of any such event specified in clause&#160;(iv) or (v) in the judgment of the Representatives makes it
        impractical or inadvisable to proceed with the public offering, sale or the delivery of the Securities on the terms and in the manner contemplated in the Pricing Disclosure Package and the Prospectus;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">After the execution and delivery of this Agreement and prior to the Time of
        Delivery (a) no downgrading shall have occurred in the rating assigned to the Company&#8217;s debt securities by a &#8220;nationally recognized statistical ratings organization&#8221; (as defined under Section 3(a)(62) of the Exchange Act) and (b) no such ratings
        organizations shall have publicly announced that it has under surveillance or review, with possible negative implications, its rating of the Company&#8217;s debt securities, the effect of which, in any event specified in clause (a) or (b), in the
        reasonable judgment of the Representatives, makes it impracticable or inadvisable to proceed with the public offering or the delivery of the Securities on the terms and in the manner contemplated in the Registration Statement, the Pricing
        Disclosure Package and the Prospectus;</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company shall have furnished or caused to be furnished to the
        Representatives at the Time of Delivery a certificate of the Company signed by an officer of the Company reasonably satisfactory to the Representatives as to (i) the accuracy of the representations and warranties of the Company herein as of the
        Time of Delivery, (ii) the performance by the Company of all of its obligations hereunder to be performed at or prior to the Time of Delivery and (iii) the matters set forth in Sections 7(b) and 7(g) hereof; and</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">On or prior to the Time of Delivery, the Company shall have furnished to
        the Representatives such further certificates and documents as the Representatives may reasonably request.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indemnification











            and Contribution</u></font>.&#160; (a)&#160; The Company will indemnify and hold harmless each Underwriter, its affiliates, directors and officers and each person, if any, who controls such Underwriter within the meaning of Section 15 of the Securities
        Act or Section 20 of the Exchange Act, from and against any losses, claims, damages or liabilities, joint or several, to which such Underwriter may become subject, under the Securities Act or otherwise, insofar as such losses, claims, damages or
        liabilities (or actions in respect thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, or any amendment thereto, or any omission or alleged
        omission to state therein a material fact required to be stated therein or necessary in order to make the statements therein not misleading or (ii) any untrue statement or alleged untrue statement of a material fact contained in the Base
        Prospectus, any Preliminary Prospectus, the Pricing Prospectus, the Prospectus, or any amendment or supplement thereto, the Pricing Disclosure Package, or any &#8220;issuer free writing prospectus&#8221; (as defined in Rule 433(d) under the Securities Act)
        relating to the offering of the Securities, or any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, and will
        reimburse each Underwriter for any legal or other expenses reasonably incurred by such Underwriter in connection with investigating or defending any such action or claim as such expenses are incurred; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font>, that the Company shall not be liable in any such case to the extent that any such loss,
        claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission in the Registration Statement, the Base Prospectus, any Preliminary Prospectus, the Pricing Prospectus, the
        Prospectus, or any amendment or supplement thereto, the Pricing Disclosure Package, or any such issuer free writing prospectus, made in reliance upon and in conformity with written information furnished to the Company by any Underwriter through the
        Representatives expressly for use therein, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in subsection (b) below.</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(b) Each Underwriter will, severally and not jointly, indemnify and hold harmless the Company, its directors, its officers and each person, if any, who controls the Company
      within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in Section 8(a) hereof, but only insofar as such losses, claims, damages or liabilities (or actions in respect
      thereof) arise out of or are based upon an untrue statement or alleged untrue statement of, or omission or alleged omission to state, a material fact made in reliance upon and in conformity with written information furnished to the Company by such
      Underwriter through the Representatives expressly for use therein, and will reimburse the Company for any legal or other expenses reasonably incurred by the Company in connection with investigating or defending any such action or claim as such
      expenses are incurred; it being understood and agreed that the only written information furnished to the Company by such Underwriter through the Representatives expressly for use in the Registration Statement, any amendment or supplement thereto, the
      Base Prospectus, any Preliminary Prospectus, the Pricing Prospectus, the Prospectus or any amendment or supplement thereto is the name of such Underwriter set forth on the cover page and the information set forth in the third, fourth, tenth and
      twenty-eighth paragraphs under the caption &#8220;Underwriting,&#8221; in each case, in the Preliminary Prospectus, the Pricing Prospectus and the Prospectus.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(c) Promptly after receipt by an indemnified party under Section 8(a) or 8(b) hereof of notice of the commencement of any action, such indemnified party shall, if a claim
      in respect thereof is to be made against the indemnifying party under such Section 8(a) or 8(b), as the case may be, notify the indemnifying party in writing of the commencement thereof; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided that</font> the failure to notify the indemnifying party shall not relieve it from any liability that it may have under the preceding paragraphs of this Section 8 except to the extent that it has been materially
      prejudiced (through the forfeiture of substantive rights or defenses) by such failure; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided further</font> that the omission to so notify the indemnifying party
      shall not relieve it from any liability which it may have to any indemnified party otherwise than under such Section 8(a) or 8(b), as the case may be.&#160; In case any such action shall be brought against any indemnified party and it shall notify the
      indemnifying party of the commencement thereof, the indemnifying party shall be entitled to participate therein and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with
      counsel reasonably satisfactory to such indemnified party and, after notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof, the indemnifying party shall not be liable to such indemnified party
      under such Section 8(a) or 8(b), as the case may be, for any legal expenses of other counsel or any other expenses, in each case subsequently incurred by such indemnified party, in connection with the defense thereof other than reasonable costs of
      investigation; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font>, that any indemnified party shall
      have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless (i) the indemnifying party and the indemnified party shall have mutually agreed to the retention of such
      counsel, (ii) the indemnifying party has failed within a reasonable time to retain counsel reasonably satisfactory to the indemnified party; (iii) the indemnified party shall have reasonably concluded that there may be legal defenses available to it
      that are different from or in addition to those available to the indemnifying party; or (iv) the named parties to any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified party and representation
      of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them.&#160; It is understood that, notwithstanding the preceding sentence of this Section 8(c), the indemnifying party shall not be liable
      for the reasonable fees and expenses of more than one separate firm (in addition to not more than one separate local counsel in any jurisdiction in which the indemnified party requires representation by separate counsel) for all such indemnified
      parties.&#160; No indemnifying party shall, without the written consent of the indemnified party, effect the settlement or compromise of, or consent to the entry of any judgment with respect to, any pending or threatened action or claim in respect of
      which indemnification or contribution may be sought hereunder (whether or not the indemnified party is an actual or potential party to such action or claim) unless such settlement, compromise or judgment (i) includes an unconditional release of the
      indemnified party from all liability arising out of such action or claim and (ii) does not include a statement as to, or an admission of, fault, culpability or a failure to act, by or on behalf of any indemnified party.&#160; An indemnifying party shall
      not be liable for any settlement effected by an indemnified party without its prior written consent, but if the settlement is made with such consent, the indemnifying party agrees to indemnify the indemnified party from and against any loss or
      liability by reason of such settlement.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(d) If the indemnification provided for in this Section 8 is unavailable to or insufficient to hold harmless an indemnified party under Section 8(a) or 8(b) hereof in
      respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred to therein, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims,
      damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters, on the other, from the offering of the Securities.&#160; If,
      however, the allocation provided by the immediately preceding sentence is not permitted by applicable law or if the indemnified party failed to give the notice required under Section 8(c) hereof, then each indemnifying party shall contribute to such
      amount paid or payable by such indemnified party in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company, on the one hand, and the Underwriters, on the other, in connection with the
      statements or omissions which resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant equitable considerations.&#160; The relative benefits received by the Company, on the one hand, and the
      Underwriters, on the other, shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received by the Company bear to the total underwriting discounts and commissions received by the
      Underwriters, in each case as set forth on the cover page of the Prospectus.&#160; The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged
      omission to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading relates to information supplied by the Company, on the one hand, or by the Underwriters, on the other, and the
      parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.&#160; The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section 8(d)
      were determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above in this Section 8(d).&#160;
      The amount paid or payable by an indemnified party as a result of the losses, claims, damages or liabilities (or actions in respect thereof) referred to above in this Section 8(d) shall be deemed to include any legal or other expenses reasonably
      incurred by such indemnified party in connection with investigating or defending any such action or claim.&#160; Notwithstanding the provisions of this Section 8(d), no Underwriter shall be required to contribute any amount in excess of the amount by
      which the total price at which the Securities underwritten by it and distributed to the public were offered to the public exceeds the amount of any damages which such Underwriter has otherwise been required to pay by reason of such untrue or alleged
      untrue statement or omission or alleged omission.&#160; No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent
      misrepresentation.&#160; The Underwriters&#8217; obligations in this Section 8(d) to contribute are several in proportion to their respective underwriting obligations and not joint.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(e) The obligations of the Company under this Section 8 shall be in addition to any liability which the Company may otherwise have and shall extend, upon the same terms and
      conditions, to each person, if any, who controls any Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act and any other affiliate (within the meaning of Rule 405 under the Securities Act) of any
      Underwriter; and the obligations of the Underwriters under this Section 8 shall be in addition to any liability which the respective Underwriters may otherwise have and shall extend, upon the same terms and conditions, to each officer and director of
      the Company, each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act and any other affiliate (within the meaning of Rule 405 under the Securities Act) of the Company.</div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Defaulting
            Underwriters</u></font>.&#160; (a)&#160; If any Underwriter shall default in its obligation to purchase the Securities which it has agreed to purchase hereunder, the Representatives may in their discretion arrange for themselves or another party or other
        parties to purchase such Securities on the terms contained herein.&#160; If within 36 hours after such default by any Underwriter the Representatives do not arrange for the purchase of such Securities, then the Company shall be entitled to a further
        period of 36 hours within which to procure another party or other parties satisfactory to the Representatives to purchase such Securities on such terms.&#160; In the event that, within the respective prescribed periods, the Representatives notify the
        Company that the Representatives have so arranged for the purchase of such Securities, or the Company notifies the Representatives that it has so arranged for the purchase of such Securities, the Representatives or the Company shall have the right
        to postpone the Time of Delivery for a period of not more than seven days, in order to effect whatever changes may thereby be made necessary in the Registration Statement or the Prospectus, or in any other documents or arrangements, and the Company
        agrees to file promptly any amendments to the Registration Statement or the Prospectus which in the Representatives&#8217; opinion may thereby be made necessary.&#160; The term &#8220;Underwriter&#8221; as used in this Agreement shall include any person substituted under
        this Section 9 with like effect as if such person had originally been a party to this Agreement with respect to such Securities.</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(b)&#160; If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the Representatives and the Company as
      provided in Section 9(a) hereof, the aggregate principal amount of such Securities which remains unpurchased does not exceed one-eleventh of the aggregate principal amount of all the Securities, then the Company shall have the right to require each
      non-defaulting Underwriter to purchase the principal amount of Securities which such Underwriter agreed to purchase hereunder and, in addition, to require each non-defaulting Underwriter to purchase its pro rata share (based on the principal amount
      of Securities which such Underwriter agreed to purchase hereunder) of the Securities of such defaulting Underwriter or Underwriters for which such arrangements have not been made; but nothing herein shall relieve a defaulting Underwriter from
      liability for its default.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(c)&#160; If after giving effect to any arrangements for the purchase of the&#160; Securities of a defaulting Underwriter or Underwriters by the Representatives and the Company as
      provided in Section 9(a) hereof, the aggregate principal amount of the Securities which remains unpurchased exceeds one-eleventh of the aggregate principal amount of all the Securities, as referred to in Section 9(b) hereof, or if the Company shall
      not exercise the right described in Section 9(b) hereof to require non-defaulting Underwriters to purchase the Securities of a defaulting Underwriter or Underwriters, then this Agreement shall thereupon terminate, without liability on the part of any
      non-defaulting Underwriter or the Company, except for the expenses to be borne by the Company and the Underwriters as provided in Section 6 hereof and the indemnity and contribution agreements in Section 8 hereof; but nothing herein shall relieve a
      defaulting Underwriter from liability for its default.</div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Survival</u></font>.&#160;











        The respective indemnities, agreements, representations, warranties and other statements of the Company and the several Underwriters, as set forth in this Agreement or made by or on behalf of them, respectively, pursuant to this Agreement, shall
        remain in full force and effect, regardless of any investigation (or any statement as to the results thereof) made by or on behalf of any Underwriter or any controlling person of any Underwriter, or the Company, or any officer or director or
        controlling person of the Company, and shall survive delivery of and payment for the Securities.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination</u></font>.&#160;











        If this Agreement shall be terminated pursuant to Section 9 hereof, the Company shall not then be under any liability to any Underwriter except as provided in Sections 6 and 8 hereof; but if for any other reason any Securities are not delivered by
        or on behalf of the Company as provided herein, the Company will reimburse the Underwriters through the Representatives for all reasonable out-of-pocket expenses approved in writing by the Representatives, including fees and disbursements of
        counsel, reasonably incurred by the Underwriters in making preparations for the purchase, sale and delivery of the Securities, but the Company shall then be under no further liability to any Underwriter except as provided in Sections 6 and 8
        hereof.</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Nature of
            Underwriters&#8217; Obligations</u></font>.&#160; The Company acknowledges and agrees that (i) the purchase and sale of the Securities pursuant to this Agreement, including the determination of the public offering price of the Securities and any related
        discounts and commissions, is an arm&#8217;s-length commercial transaction between the Company, on the one hand, and the several Underwriters, on the other hand, (ii) in connection with the offering contemplated hereby and the process leading to such
        transaction, each Underwriter is, and has been, acting solely as a principal and is not the agent or fiduciary of the Company directly or indirectly, (iii) no Underwriter has assumed, or will assume, an advisory or fiduciary responsibility in favor
        of the Company with respect to the offering contemplated hereby or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company on other matters) and no Underwriter has any similar
        obligation to the Company with respect to the offering of the Securities contemplated hereby except the obligations expressly set forth in this Agreement and (iv) the Company has consulted its own legal and financial advisors to the extent it
        deemed appropriate. Any review by any of the Underwriters of the Company, the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of such Underwriters and shall not be on behalf
        of the Company or any other person.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">13.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Authority
            of Representatives</u></font>.&#160; In all dealings hereunder, the Representatives shall act on behalf of each of the Underwriters, and the Company shall be entitled to act and rely upon any statement, request, notice or agreement on behalf of any
        Underwriter made or given by the Representatives jointly or by any Representative and may assume that such statement, request, notice or agreement has been duly authorized by such Underwriter.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">14.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Notices</u></font>.&#160;











        All statements, requests, notices and agreements hereunder shall be in writing or by telephone if promptly confirmed in writing, and if to the Underwriters, shall be sufficient in all respects if delivered or sent by facsimile transmission or
        registered mail to the Representatives (i) c/o Deutsche Bank Securities Inc., 60 Wall Street, New York, New York&#160; 10005, Attention: Debt Capital Markets Syndicate, with a copy to General Counsel, fax: (646) 374-1071; (ii) c/o J.P. Morgan Securities
        LLC, 383 Madison Avenue, New York, New York 10179, Attn: Investment Grade Syndicate Desk, 3rd Fl., fax: (212) 834-6081; (iii) c/o Truist Securities, Inc., 3333 Peachtree Road NE, 11<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor, Atlanta, Georgia 30326, Attention: Investment
        Grade Capital Markets, fax: (404) 926-5027; and (iv)&#160;c/o Wells Fargo Securities, LLC, 550 Tryon Street, 5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor, Charlotte, North Carolina 28202, Attention: Transaction Management, email: tmgcapitalmarkets@wellsfargo.com; if to the
        Company, shall be sufficient in all respects if delivered or sent by facsimile transmission or registered mail to Martin Marietta Materials, Inc., 4123 Parklake Avenue, Raleigh, North Carolina, 27612, Attention: General Counsel (Fax: (855)
        783-4603).</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">15.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Persons
            Entitled to Benefit of Agreement</u></font>.&#160; This Agreement shall be binding upon, and inure solely to the benefit of, the Underwriters, the Company and, to the extent provided in Sections 8 and 10 hereof, the officers and directors of the
        Company, each person who controls the Company or any Underwriter and any other affiliate of any Underwriter, and their respective heirs, executors, administrators, successors and assigns, and no other person shall acquire or have any right under or
        by virtue of this Agreement.&#160; No purchaser of any of the Securities from any Underwriter shall be deemed a successor or assign by reason merely of such purchase.</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">16.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Time of
            Essence</u></font>.&#160; Time shall be of the essence of this Agreement.&#160; As used herein, the term &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>business day</u></font>&#8221; shall mean any day, other than a Saturday or a Sunday,
        which is not a day or which banking institutions in New York, New York are authorized or obligated by law or executive order to close.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">17.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Definitive











            Agreement</u></font>.&#160; This Agreement supersedes all prior agreements and understandings (written or oral) between the Company and the Underwriters, or any of them, with respect to the subject matter hereof.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">18.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Governing
            Law</u></font>.&#160; This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by, and construed in accordance with, the laws of the State of New York.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">19.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Waiver of
            Jury Trial</u></font>.&#160; The Company and each of the Underwriters hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this
        Agreement or the transactions contemplated hereby.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">20.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Counterparts</u></font>.&#160;











        This Agreement may be executed by any one or more of the parties hereto in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same instrument. The words
        &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; &#8220;delivery,&#8221; and words of like import in or relating to this Agreement or any&#160; document to be signed in connection with this Agreement shall be deemed to include electronic signatures, deliveries or the keeping of
        records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the
        parties hereto consent to conduct the transactions contemplated hereunder by electronic means.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">21.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Recognition











            of the U.S. Special Resolution Regimes.</u></font>&#160; (a) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and
        any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the
        laws of the United States or a state of the United States.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">In the event that any Underwriter that is a Covered
        Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater
        extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>BHC Act Affiliate</u></font>&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and
      shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k). </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Covered Entity</u></font>&#8221; means any of the following:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">a &#8220;covered entity&#8221; as that term is defined in, and
        interpreted in accordance with, 12 C.F.R. &#167; 252.82(b);</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">24</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">a &#8220;covered bank&#8221; as that term is defined in, and
        interpreted in accordance</font> with, 12 C.F.R. &#167; 47.3(b); or </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"> a &#8220;covered FSI&#8221; as the term is defined in, and
        interpreted in accordance</font> with, 12 C.F.R. &#167; 382.2(b). </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Default Right</u></font>&#8221; has the meaning assigned to that term in, and shall be
      interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>U.S. Special Resolution Regime</u></font>&#8221; means each of (i) the Federal Deposit
      Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">22.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Patriot
            Act.</u></font> In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective
        clients, including the Company, which information may include the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients.</font></div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Signature pages follow</font>]</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">25</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If the foregoing is in accordance with the Representatives&#8217; understanding, please sign and return to us a counterpart hereof, and upon the acceptance
      hereof by the Representatives, on behalf of each of the Underwriters, this letter and such acceptance hereof shall constitute a binding agreement between each of the Underwriters and the Company.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">It is understood that the Representatives&#8217; acceptance of this letter on behalf of each of the Underwriters is pursuant to the authority set forth in a
      form of an Agreement among the Underwriters, copies of which, to the extent practicable and upon request, shall be submitted to the Company for examination, but without any representation or warranty on the Representatives&#8217; part as to the authority
      of the senders thereof.</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr>
            <td valign="top" rowspan="1" style="width: 50%;">&#160;</td>
            <td valign="top" rowspan="1" colspan="3">Very truly yours,</td>
            <td valign="top" rowspan="1" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" rowspan="1" style="width: 50%;">&#160;</td>
            <td valign="top" rowspan="1" colspan="3">&#160;</td>
            <td valign="top" rowspan="1" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" colspan="3">MARTIN MARIETTA MATERIALS, INC.</td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" colspan="2">&#160;</td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" rowspan="1" style="width: 50%;">&#160;</td>
            <td valign="top" rowspan="1" style="width: 3%;">&#160;</td>
            <td valign="top" rowspan="1" colspan="2">&#160;</td>
            <td valign="top" rowspan="1" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
              </div>
            </td>
            <td valign="top" style="width: 3%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
            </td>
            <td valign="top" nowrap="nowrap" align="left" colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0);">/s/ C. Howard Nye<br>
            </td>
            <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 4%;">Name:</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 31%;">C. Howard Nye</td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" style="width: 4%;">Title:</td>
            <td valign="top" style="width: 31%;">President and CEO<br>
            </td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" colspan="2">&#160;</td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>

      </table>
    </div>
    <br>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[Signature Page to Underwriting Agreement]</div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For themselves and on behalf of the several Underwriters listed in Schedule I hereto.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Accepted as of the date first written above at New York,</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">New York:</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr>
            <td valign="top" colspan="3" rowspan="1">&#160;</td>
            <td valign="top" style="width: 12%;" rowspan="1">&#160;</td>
            <td valign="top" colspan="1" style="width: 50%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td valign="top" colspan="3" rowspan="1">&#160;</td>
            <td valign="top" style="width: 12%;" rowspan="1">&#160;</td>
            <td valign="top" colspan="1" style="width: 50%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td valign="top" colspan="3">DEUTSCHE BANK SECURITIES INC.</td>
            <td valign="top" style="width: 12%;">&#160;</td>
            <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" colspan="2">&#160;</td>
            <td valign="top" style="width: 12%;">&#160;</td>
            <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 3%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
            </td>
            <td valign="top" nowrap="nowrap" align="left" colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0);">/s/ Rita S. Ketkar<br>
            </td>
            <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
            <td valign="top" colspan="1" style="width: 50%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 4%;">Name:</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 31%;">Rita Ketkar<br>
            </td>
            <td valign="top" style="width: 12%;">&#160;</td>
            <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" style="width: 4%;">Title:</td>
            <td valign="top" style="width: 31%;">Managing Director<br>
            </td>
            <td valign="top" style="width: 12%;">&#160;</td>
            <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" colspan="2">&#160;</td>
            <td valign="top" style="width: 12%;">&#160;</td>
            <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr>
            <td valign="top" style="width: 3%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
            </td>
            <td valign="top" nowrap="nowrap" align="left" colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0);">/s/ John C. McCabe<br>
            </td>
            <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
            <td valign="top" colspan="1" style="width: 50%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 4%;">Name:</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 31%;">John C. McCabe<br>
            </td>
            <td valign="top" style="width: 12%;">&#160;</td>
            <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" style="width: 4%;">Title:</td>
            <td valign="top" style="width: 31%;">Managing Director<br>
            </td>
            <td valign="top" style="width: 12%;">&#160;</td>
            <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" colspan="2">&#160;</td>
            <td valign="top" style="width: 12%;">&#160;</td>
            <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman'; font-size: 10pt;">

            <tr>
              <td valign="top" colspan="3">J.P. MORGAN SECURITIES LLC</td>
              <td valign="top" style="width: 12%;">&#160;</td>
              <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" colspan="2">&#160;</td>
              <td valign="top" style="width: 12%;">&#160;</td>
              <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 3%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
              </td>
              <td valign="top" nowrap="nowrap" align="left" colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0);">/s/ Robert Bottamedi<br>
              </td>
              <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
              <td valign="top" colspan="1" style="width: 50%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" align="left" style="width: 4%;">Name:</td>
              <td valign="bottom" nowrap="nowrap" align="left" style="width: 31%;">Robert Bottamedi<br>
              </td>
              <td valign="top" style="width: 12%;">&#160;</td>
              <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 4%;">Title:</td>
              <td valign="top" style="width: 31%;">Executive Director<br>
              </td>
              <td valign="top" style="width: 12%;">&#160;</td>
              <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" colspan="2">&#160;</td>
              <td valign="top" style="width: 12%;">&#160;</td>
              <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
            </tr>

        </table>
      </div>
      <div>
        <div> </div>
      </div>
    </div>
    <div><br>
    </div>
    <div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman'; font-size: 10pt;">

              <tr>
                <td valign="top" colspan="3">TRUIST SECURITIES, INC.</td>
                <td valign="top" style="width: 12%;">&#160;</td>
                <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="top" colspan="2">&#160;</td>
                <td valign="top" style="width: 12%;">&#160;</td>
                <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 3%; padding-bottom: 2px;">
                  <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
                </td>
                <td valign="top" nowrap="nowrap" align="left" colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0);">/s/ Robert Nordlinger<br>
                </td>
                <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
                <td valign="top" colspan="1" style="width: 50%; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" align="left" style="width: 4%;">Name:</td>
                <td valign="bottom" nowrap="nowrap" align="left" style="width: 31%;">Robert Nordlinger<br>
                </td>
                <td valign="top" style="width: 12%;">&#160;</td>
                <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="top" style="width: 4%;">Title:</td>
                <td valign="top" style="width: 31%;">Director<br>
                </td>
                <td valign="top" style="width: 12%;">&#160;</td>
                <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="top" colspan="2">&#160;</td>
                <td valign="top" style="width: 12%;">&#160;</td>
                <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
              </tr>

          </table>
        </div>
        <div><br>
        </div>
      </div>
    </div>
    <div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman'; font-size: 10pt;">

              <tr>
                <td valign="top" colspan="3">WELLS FARGO SECURITIES, INC.</td>
                <td valign="top" style="width: 12%;">&#160;</td>
                <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="top" colspan="2">&#160;</td>
                <td valign="top" style="width: 12%;">&#160;</td>
                <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 3%; padding-bottom: 2px;">
                  <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
                </td>
                <td valign="top" nowrap="nowrap" align="left" colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0);">/s/ Carolyn Hurley<br>
                </td>
                <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
                <td valign="top" colspan="1" style="width: 50%; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" align="left" style="width: 4%;">Name:</td>
                <td valign="bottom" nowrap="nowrap" align="left" style="width: 31%;">Carolyn Hurley<br>
                </td>
                <td valign="top" style="width: 12%;">&#160;</td>
                <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="top" style="width: 4%;">Title:</td>
                <td valign="top" style="width: 31%;">Managing Director<br>
                </td>
                <td valign="top" style="width: 12%;">&#160;</td>
                <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="top" colspan="2">&#160;</td>
                <td valign="top" style="width: 12%;">&#160;</td>
                <td valign="top" colspan="1" style="width: 50%;">&#160;</td>
              </tr>

          </table>
        </div>
        <div><br>
        </div>
      </div>
    </div>
    <br>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[Signature Page to Underwriting Agreement]</div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%I-%%-->
    <div><br>
    </div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SCHEDULE I</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div> </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" id="zfa3468867c4340999ed8f2300e8c40c9" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 46%; vertical-align: top; padding-bottom: 2px;">
              <div>&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Underwriter</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 17%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">0.650%</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Senior Notes</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> due 2023</div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 17%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">2.400%</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Senior Notes due</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> 2031</div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 17%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">3.200%</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Senior Notes due</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">2051</div>
            </td>
          </tr>
          <tr>
            <td style="width: 46%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Deutsche Bank Securities Inc.</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 17%; vertical-align: middle;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">$140,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: middle;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">$180,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">$180,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 46%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">J.P. Morgan Securities LLC</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;140,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;180,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;180,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 46%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Truist Securities, Inc.</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;140,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;180,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;180,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 46%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Wells Fargo Securities, LLC</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;140,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;180,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;180,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 46%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Loop Capital Markets LLC</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;35,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;45,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;45,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 46%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">PNC Capital Markets LLC</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;35,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;45,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;45,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 46%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Regions Securities LLC</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;35,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;45,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;45,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 46%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">MUFG Securities Americas Inc.</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;21,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;27,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;27,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 46%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Comerica Securities, Inc.</div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 17%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;14,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right; padding-bottom: 2px;">&#160;</td>
            <td style="width: 17%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;18,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: top; text-align: right; padding-bottom: 2px;">&#160;</td>
            <td style="width: 17%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;18,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 46%; vertical-align: top;">
              <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 17%; vertical-align: bottom; text-align: right;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">$700,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: bottom; text-align: right;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">$900,000,000</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="width: 17%; vertical-align: bottom; text-align: right;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">$900,000,000</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">I-1</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%II-%%-->
    <div><br>
    </div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SCHEDULE II</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ISSUER FREE WRITING PROSPECTUSES</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfa3da3ae2a174598aba6cbaab24ef220">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: Times New Roman">&#9679;</font></td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Pricing Term Sheet, dated June 21, 2021, relating to the Securities, substantially in the form of Annex A hereto, which will be filed pursuant to Rule 433 under the Securities Act.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">II-1</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%ANNEX A-%%-->
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ANNEX A</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <div>
        <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Filed Pursuant to Rule 433</div>
        <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Registration&#160;No.&#160;333-238199</div>
        <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Issuer Free Writing Prospectus dated June 21, 2021</div>
        <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Relating to Preliminary Prospectus Supplement dated June 21, 2021</div>
      </div>
      <div><br>
      </div>
      <div>
        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">MARTIN MARIETTA MATERIALS, INC.</div>
        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$700,000,000 0.650% Senior Notes due 2023</div>
        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$900,000,000 2.400% Senior Notes due 2031</div>
        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$900,000,000 3.200% Senior Notes due 2051</div>
      </div>
      <div><br>
      </div>
      <div>
        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PRICING TERM SHEET</div>
        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">JUNE 21, 2021</div>
        <div><br>
        </div>
      </div>
      <div style="font-weight: normal;">
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">This term sheet (this &#8220;Pricing Term Sheet&#8221;) relates only to the securities described below and is qualified in its entirety by reference to the
          preliminary prospectus supplement, dated June 21, 2021, of Martin Marietta Materials, Inc. (the &#8220;Preliminary Prospectus Supplement&#8221;). The information in this Pricing Term Sheet supplements the Preliminary Prospectus Supplement and supersedes the
          information in the Preliminary Prospectus Supplement only to the extent it is inconsistent with the information contained in the Preliminary Prospectus Supplement. Capitalized terms used but not defined herein have the meanings given to them in
          the Preliminary Prospectus Supplement.</div>
      </div>
      <div>
        <div><br>
        </div>
        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>0.650% SENIOR NOTES DUE 2023</u></div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z3b8346a735984fe2854ab38be10bf398" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Issuer:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Martin Marietta Materials, Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Security:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">0.650% Senior Notes due 2023 (the &#8220;2023 Notes&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Principal Amount:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">$700,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Maturity Date:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">July 15, 2023</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Issue Price:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">99.988% of principal amount, plus accrued interest, if any, from and including, July 2, 2021</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Benchmark Treasury:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">UST 0.125% due May 15, 2023<br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Benchmark Treasury Price and Yield:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;99-23 7/8 and 0.256%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Spread to Benchmark Treasury:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Plus 40 basis points</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Yield to Maturity:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">0.656<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;"></font>%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Coupon (Interest Rate):</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">0.650%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Interest Payment Dates:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Semi-annually on January 15 and July 15, commencing on January 15, 2022</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Gross Proceeds to the Issuer:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">$699,916,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Optional Redemption:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Prior to July 2, 2022 (one year after the date that the 2023 Notes are issued) (the &#8220;2023 Par Call Date&#8221;), make-whole call at any time at a discount rate of U.S.
                Treasury Rate plus 10 basis points (or 0.10<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"></font>%)</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 8pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On or after the 2023 Par Call Date, at any time at a redemption price equal to 100% of the principal amount, plus accrued and unpaid interest to, but excluding,
                the date of redemption</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Day Count Convention:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">30/360</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CUSIP / ISIN:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">573284 AY2 / US573284AY29</div>
            </td>
          </tr>

      </table>
      <div>
        <div><br>
        </div>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">ANNEX A-1</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>2.400% SENIOR NOTES DUE 2031</u></div>
      </div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="za79ac66c325c4877964ab1a2d634edb2" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Issuer:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Martin Marietta Materials, Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Security:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">2.400% Senior Notes due 2031 (the &#8220;2031 Notes&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Principal Amount:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">$900,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Maturity Date:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">July 15, 2031</div>
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Issue Price:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">99.937% of principal amount, plus accrued interest, if any, from and including, July 2, 2021</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Benchmark Treasury:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">UST 1.625% due May 15, 2031<br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Benchmark Treasury Price and Yield:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">101-08+ and 1.487%<br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Spread to Benchmark Treasury:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Plus 92 basis points</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Yield to Maturity:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">2.407%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Coupon (Interest Rate):</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">2.400%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Interest Payment Dates:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Semi-annually on January 15 and July 15, commencing on January 15, 2022</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Gross Proceeds to the Issuer:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">$899,433,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div>&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Special Mandatory Redemption:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">&#160;</td>
            <td style="width: 69%; vertical-align: bottom;">
              <div>&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Mandatorily redeemable at 101% of the principal plus accrued and unpaid interest to, but excluding, the Special Mandatory Redemption Date if (i) the Acquisition
                is not consummated prior to March 31, 2022, (ii) the Purchase Agreement is terminated at any time prior to March 31, 2022 (other than as a result of consummating the Acquisition) or (iii) the Issuer publicly announces at any time prior to
                March 31, 2022 that it will no longer pursue the consummation of the Acquisition</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Optional Redemption:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Prior to April 15<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">, 2031</font> (three months prior to the maturity date of the 2031
                Notes) (the &#8220;2031 Par Call Date&#8221;), make-whole call at any time at a discount rate of U.S. Treasury Rate plus 15 basis points (or 0.15%)</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 8pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On or after the 2031 Par Call Date, at any time at a redemption price equal to 100% of the principal amount, plus accrued and unpaid interest to, but excluding,
                the date of redemption</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Day Count Convention:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">30/360</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CUSIP / ISIN:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">573284 AW6<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;"> </font>/ US573284AW62<br>
              </div>
            </td>
          </tr>

      </table>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">ANNEX A-2</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>3.200% SENIOR NOTES DUE 2051</u></div>
      </div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z889a1b9eeeca4d82a764f040dddae579" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Issuer:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Martin Marietta Materials, Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Security:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.200% Senior Notes due 2051 (the &#8220;2051 Notes&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Principal Amount:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">$900,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Maturity Date:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">July 15, 2051</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Issue Price:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">99.197% of principal amount, plus accrued interest, if any, from and including, July 2, 2021</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Benchmark Treasury:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">UST 1.875% due February 15, 2051<br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Benchmark Treasury Price and Yield:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">94-19 and 2.122%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Spread to Benchmark Treasury:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Plus 112 basis points</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Yield to Maturity:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.242%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Coupon (Interest Rate):</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.200%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Interest Payment Dates:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Semi-annually on January 15 and July 15, commencing on January 15, 2022</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Gross Proceeds to the Issuer:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">$892,773,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div>&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Special Mandatory Redemption:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">&#160;</td>
            <td style="width: 69%; vertical-align: bottom;">
              <div>&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Mandatorily redeemable at 101% of the principal plus accrued and unpaid interest to, but excluding, the Special Mandatory Redemption Date if (i) the Acquisition
                is not consummated prior to March 31, 2022, (ii) the Purchase Agreement is terminated at any time prior to March 31, 2022 (other than as a result of consummating the Acquisition) or (iii) the Issuer publicly announces at any time prior to
                March 31, 2022 that it will no longer pursue the consummation of the Acquisition</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Optional Redemption:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Prior to January 15, 2051 (six months prior to the maturity date of the 2051 Notes) (the &#8220;2051 Par Call Date&#8221;), make-whole call at any time at a discount rate of
                U.S. Treasury Rate plus 20 basis points (or 0.20%)</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 8pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On or after the 2051 Par Call Date, at any time at a redemption price equal to 100% of the principal amount, plus accrued and unpaid interest to, but excluding,
                the date of redemption</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Day Count Convention:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">30/360</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CUSIP / ISIN:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">573284 AX4<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;"> </font>/ US573284AX46</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">&#160;</td>
            <td style="width: 1%; vertical-align: bottom;">&#160;</td>
            <td style="width: 69%; vertical-align: bottom;">&#160;</td>
          </tr>

      </table>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">ANNEX A-3</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>2023 NOTES, 2031 NOTES AND 2051 NOTES</u></div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zbf358b17b0624ab3973ef988a38857f6" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 30%; vertical-align: bottom;">
              <div style="text-align: left; text-indent: -12pt; margin-left: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ratings:*</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">&#160;</td>
            <td style="width: 69%; vertical-align: bottom;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: bottom;">
              <div style="text-align: left; text-indent: -12pt; margin-left: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Trade Date:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">June <font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">21</font>, 2021</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; text-indent: -12pt; margin-left: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Settlement Date:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">July 2, 2021 (T+9)</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 8pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">We expect that delivery of the 2023 Notes, 2031 Notes and 2051 Notes (collectively, the &#8220;Notes&#8221;) will be made to investors on or about July 2, 2021, which will be
                the ninth business day following the date of the prospectus supplement (such settlement cycle being referred to as &#8220;T+9&#8221;). Under Rule&#160;15c6-1&#160;under the Securities Exchange Act of 1934, as amended, trades in the secondary market are required
                to settle in two business days, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes any date prior to the second business day before delivery will be required, by virtue of the
                fact that the Notes initially settle in T+9, to specify an alternate settlement arrangement at the time of any such trade to prevent a failed settlement. Purchasers of the Notes who wish to trade the Notes prior to the second business day
                preceding the delivery date of the Notes should consult their advisors.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: bottom;">
              <div style="text-align: left; text-indent: -12pt; margin-left: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Legal Format:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">SEC Registered</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: bottom;">
              <div style="text-align: left; text-indent: -12pt; margin-left: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Denominations:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">$2,000 x $1,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Joint Book-Running Managers:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Deutsche Bank Securities Inc.</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">J.P. Morgan Securities LLC</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Truist Securities, Inc.</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Wells Fargo Securities, LLC</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: left; text-indent: -12pt; margin-left: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Co-Managers:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;</div>
            </td>
            <td style="width: 69%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Loop Capital Markets LLC</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">PNC Capital Markets LLC</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Regions Securities LLC</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">MUFG Securities Americas Inc.</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Comerica Securities, Inc.</div>
            </td>
          </tr>

      </table>
      <div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zef91ba9bb0a84467954f9fa4473d28b2" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 2%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">*</div>
            </td>
            <td style="width: 98%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">This communication is intended for the sole use of the person to whom it is provided by us.</div>
      </div>
      <div><br>
      </div>
      <div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">The Issuer has filed a registration statement (including a prospectus) with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;)
          for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, and other documents the Issuer has filed with the SEC for more complete information about the Issuer and this
          offering. You may get these documents for free by visiting EDGAR on the SEC website at&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">www.sec.gov</font>.</div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Alternatively, the Issuer, any underwriter or any dealer participating in this offering will arrange to send you a copy of the
          prospectus upon request. Interested parties may obtain a prospectus and the related prospectus supplement from Deutsche Bank Securities Inc., 60 Wall Street, New York, New York 10005, Attn: Prospectus Group by telephone at (800) 503-4611 or by
          email at prospectus.CPDG@db.com; J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attn:&#160; Investment Grade Syndicate Desk&#8212;3rd Floor or by telephone at (212) 834-4533; Truist Securities, Inc., 303 Peachtree Street, Atlanta,
          Georgia 30308, Attention: Prospectus Dept or by telephone at (800) 685-4786; and Wells Fargo Securities, LLC, 608 2nd Avenue South, Suite 1000, Minneapolis, MN 55402, Attention: WFS Customer Service by telephone at (800) 645-3751 or by email at
          wfscustomerservice@wellsfargo.com.</div>
      </div>
      <div><br>
      </div>
      <div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such
          disclaimer or other notice was automatically generated as a result of this communication being sent via Bloomberg or another email system.</div>
      </div>
    </div>
    <div></div>
    <div></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">ANNEX A-4</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%III-%%-->
    <div><br>
    </div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SCHEDULE III</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FORM OF OPINION AND NEGATIVE ASSURANCE LETTER OF COUNSEL FOR THE COMPANY</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">June [&#9679;], 2021</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Martin Marietta Materials, Inc.</u></font><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>$[&#9679;] Aggregate Principal Amount of [&#9679;]% Senior Notes due 2023</u></font></div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>$[&#9679;] Aggregate Principal Amount of [&#9679;]% Senior Notes due 2031</u></div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>$[&#9679;] Aggregate Principal Amount of [&#9679;]% Senior Notes due 2051</u></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ladies and Gentlemen:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">We have acted as counsel for Martin Marietta Materials, Inc., a North Carolina corporation (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Company</u></font>&#8221;), in connection with the purchase by the several Underwriters (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Underwriters</u></font>&#8221;) listed in Schedule I to the Underwriting Agreement dated
      June [&#9679;], 2021 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Underwriting Agreement</u></font>&#8221;), among the Company and Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Truist Securities, Inc. and Wells Fargo
      Securities, LLC, as representatives of the several Underwriters, with respect to the offering and sale of $[&#9679;] aggregate principal amount of the Company&#8217;s [&#9679;]% Senior Notes due 2023 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>2023











          Notes</u></font>&#8221;), $[&#9679;] aggregate principal amount of the Company&#8217;s [&#9679;]% Senior Notes due 2031 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>2031 Notes</u></font>&#8221;) and $[&#9679;] aggregate principal amount of the Company&#8217;s
      [&#9679;]% Senior Notes due 2051 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>2051 Notes</u></font>&#8221; and, together with the 2023 Notes and the 2031 Notes, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Notes</u></font>&#8221;)











      to be issued pursuant to an Indenture dated as of May 22, 2017 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Base Indenture</u></font>&#8221;), between the Company and Regions Bank (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Trustee</u></font>&#8221;), as amended and supplemented by the Fourth Supplemental Indenture dated as of June [&#9679;], 2021 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Fourth Supplemental Indenture</u></font>&#8221;
      and, together with the Base Indenture, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indenture</u></font>&#8221;), between the Company and the Trustee.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">In that connection, we have examined originals, or copies certified or otherwise identified to our satisfaction, of such documents, corporate records and
      other instruments as we have deemed necessary or appropriate for the purposes of this opinion, including:&#160; (a)&#160;the Registration Statement on Form&#160;S&#8209;3 (Registration No. 333&#8209;238199) filed with the Securities and Exchange Commission (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Commission</u></font>&#8221;) on May 12, 2020, for registration under the Securities Act of 1933, as amended (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Securities
          Act</u></font>&#8221;), of various securities of the Company, to be issued from time to time by the Company (such Registration Statement being hereinafter referred to as the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Registration











          Statement</u></font>&#8221;); (b)&#160;the related Prospectus dated May 12, 2020 (together with the documents incorporated therein by reference, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Basic Prospectus</u></font>&#8221;); (c)&#160;the
      Prospectus Supplement dated June [&#9679;], 2021, filed with the Commission pursuant to Rule&#160;424(b) of the General Rules and Regulations under the Securities Act (together with the Basic Prospectus, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Prospectus</u></font>&#8221;); (d) the documents and other information described in Annex A to this letter (together, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Specified Disclosure Package</u></font>&#8221;);
      (e)&#160;the Underwriting Agreement; (f)&#160;the Indenture and the form of the Notes; and (g) the agreements specified on Schedule 1 hereto (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Specified Agreements</u></font>&#8221;).&#160;











      We have also relied upon advice from the Commission that the Registration Statement initially became effective on May 12, 2020.&#160; We have relied, with respect to certain factual matters, on statements of officers and other representatives of the
      Company and the representations and warranties of the Company and the Underwriters contained in the Underwriting Agreement and have assumed compliance by each such party with the terms of the Underwriting Agreement.&#160; In particular, we have relied
      upon the Company&#8217;s representation that it has not been notified pursuant to Rule 401(g) of the Securities Act of any objection by the Commission to the use of the form on which the Registration Statement was filed.&#160; We have assumed, with your consent
      and without independent investigation or verification, the genuineness of all signatures, the legal capacity and competency of all natural persons, the authenticity of all documents submitted to us as originals and the conformity to authentic
      original documents of all documents submitted to us as duplicates or copies.&#160; In addition, we have relied on a certificate of an officer of the Company as to certain factual matters.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">III-1</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">Our identification of information as part of the Specified Disclosure Package has been at your request and with your approval.&#160; Such identification is
      for the limited purpose of making the statements set forth in this opinion regarding the Specified Disclosure Package and is not the expression of a view by us as to whether any such information has been or should have been conveyed to investors
      generally or to any particular investors at any particular time or in any particular manner.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">Based on the foregoing and subject to the qualifications set forth herein, we are of opinion as follows:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Notes conform in all material respects to the
        description thereof contained in the Prospectus and the Specified Disclosure Package.&#160; The statements made in the Prospectus and the Specified Disclosure Package under the caption &#8220;Material U.S. Federal Income Tax Considerations&#8221;, insofar as they
        purport to describe the material tax consequences of an investment in the Notes, fairly summarize the matters therein described in all material respects.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Assuming the Base Indenture and the Fourth Supplemental
        Indenture have been duly authorized, executed and delivered by the Company, the Indenture has been duly qualified under the Trust Indenture Act of 1939, as amended (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Trust
            Indenture Act</u></font>&#8221;), and constitutes a legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms (subject to applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent
        transfer and other similar laws affecting creditors&#8217; rights generally from time to time in effect and to general principles of equity, including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing, regardless
        of whether considered in a proceeding in equity or at law); and, assuming the Notes have been duly authorized, executed and delivered by the Company, when executed and authenticated in accordance with the provisions of the Indenture and delivered
        to and paid for by the Underwriters pursuant to the Underwriting Agreement, the Notes will constitute legal, valid and binding obligations of the Company entitled to the benefits of the Indenture and enforceable against the Company in accordance
        with their terms (subject to applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer and other similar laws affecting creditors&#8217; rights generally from time to time in effect and to general principles of equity, including,
        without limitation, concepts of materiality, reasonableness, good faith and fair dealing, regardless of whether considered in a proceeding in equity or at law).</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">III-2</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">No authorization, approval or other action by, and no
        notice to, consent of, order of, or filing with, any United States Federal or New York State governmental authority is required to be made or obtained by the Company for the consummation of the transactions contemplated by the Underwriting
        Agreement, other than (i) those that have been obtained or made under the Securities Act or the Trust Indenture Act, (ii) those that may be required under the Securities Act in connection with the use of a &#8220;free writing prospectus&#8221; and (iii) those
        that may be required under the blue sky laws of any jurisdiction in connection with the purchase and distribution of the Notes by the Underwriters.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Registration Statement initially became effective
        under the Securities Act on May 12, 2020, and, assuming prior payment by the Company of the pay-as-you-go registration fee for the offering of the Notes, upon filing of the Prospectus with the Commission the offering of the Notes as contemplated by
        the Prospectus became registered under the Securities Act; to our knowledge, no stop order suspending the effectiveness of the Registration Statement has been issued and no proceedings for that purpose have been instituted or are pending or
        contemplated under the Securities Act.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The issue and sale by the Company of the Notes, the
        execution and delivery by the Company of the Underwriting Agreement and the Indenture, the consummation of the other transactions contemplated by the Underwriting Agreement and the Indenture and the performance by the Company of its obligations
        under the Underwriting Agreement and the Indenture do not result in a breach of or constitute a default under the express terms and conditions of any Specified Agreement and will not violate any law, rule or regulation of the United States of
        America or the State of New York of the type that in our experience typically would be applicable to transactions of the type contemplated by the Underwriting Agreement.&#160; The foregoing opinion relating to the Specified Agreements does not extend to
        compliance with any financial ratio or any limitation in any contractual restriction expressed as a dollar amount (or an amount expressed in another currency).</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Based solely on the certificate dated the date hereof
        from an officer of the Company, attached as Annex B hereto, the Company is not required to register as an &#8220;investment company&#8221; as such term is defined in the Investment Company Act of 1940, as amended.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Underwriting Agreement has been duly executed and
        delivered by the Company.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">We express no opinion with respect to compliance with, or the application or effect of, Federal or state securities or Blue Sky laws except, with respect
      to Federal securities laws, to the extent set forth in paragraph (2) with respect to the qualification of the Indenture under the Trust Indenture Act and in paragraphs (4) and (6).</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">We express no opinion herein as to any provision of the Indenture or the Notes that (a) relates to the subject matter jurisdiction of any Federal court
      of the United States of America, or any Federal appellate court, to adjudicate any controversy related to the Indenture or the Notes, (b) contains a waiver of an inconvenient forum or (c) relates to the waiver of rights to jury trial.&#160; We also
      express no opinion as to whether a state court outside the State of New York or a Federal court of the United States would give effect to the choice of New York law provided for in the Indenture or the Notes.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">III-3</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">We understand that you are satisfying yourselves as to the status under Section 548 of the Bankruptcy Code and applicable state fraudulent conveyance
      laws of the obligations of the Company under the Indenture and the Notes, and we express no opinion thereon.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">We are admitted to practice in the State of New York, and we express no opinion as to matters governed by any laws other than the laws of the State of
      New York and the Federal laws of the United States of America.&#160; In particular, we do not purport to pass on any matter governed by the laws of the State of North Carolina.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">We are furnishing this opinion to you solely for your benefit.&#160; This opinion may not be relied upon by any other person (including by any person that
      acquires the Notes from you) or for any other purpose.&#160; It may not be used, circulated, quoted or otherwise referred to for any other purpose.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Very truly yours,</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Deutsche Bank Securities Inc.</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">J.P. Morgan Securities LLC</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Truist Securities, Inc.</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Wells Fargo Securities, LLC</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">and the several other Underwriters</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">listed on Schedule I to the Underwriting Agreement,</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o Deutsche Bank Securities Inc.</div>
    <div style="text-align: justify; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">60 Wall Street</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">New York, New York 10005</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o J.P. Morgan Securities LLC</div>
    <div style="text-align: justify; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">383 Madison Avenue</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">New York, New York 10179</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o Truist Securities, Inc.</div>
    <div style="text-align: justify; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">3333 Peachtree Road NE, 11<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Atlanta, Georgia 30326</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o Wells Fargo Securities, LLC</div>
    <div style="text-align: justify; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">550 South Tryon Street, 5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Charlotte, North Carolina 28202</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">120A</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">O</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">III-4</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Schedule 1</u></div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z248324bcbf9c42108a7ddcfff2795cd8">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Indenture dated as of December 1, 1995, between Martin Marietta Materials, Inc. and First Union National Bank of North Carolina, as trustee.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbce49b031f3246feab4e9568fd031e5f">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Indenture dated as of April 30, 2007, between Martin Marietta Materials, Inc. and Truist Bank (as successor by merger to SunTrust Bank and formerly known as Branch Banking and Trust
              Company), as trustee (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>2007 Base Indenture</u></font>&#8221;).</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2e044bd599c8434bba9b0fbe2861d76c">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Second Supplemental Indenture to the 2007 Base Indenture dated as of April 30, 2007, between Martin Marietta Materials, Inc. and Truist Bank, as trustee.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z31d84dc2a63b4fa7a821066517c2432e">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Indenture dated as of July 2, 2014, between Martin Marietta Materials, Inc. and Regions Bank, as trustee.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5f2638d7295d4830b6b037034a7e5236">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Credit and Security Agreement dated as of April 19, 2013, among Martin Marietta Funding LLC, as borrower, Martin Marietta Materials, Inc., as servicer, the lenders and other parties
              party thereto from time to time and Truist Bank, as Administrative Agent, as amended through the date hereof.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z22c2524bae7e4e0982bcd643d996f050">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Credit Agreement dated as of December 5, 2016, among Martin Marietta Materials, Inc., JPMorgan Chase Bank, N.A., as Administrative Agent, Wells Fargo Bank, N.A., Truist Bank and
              Deutsche Bank Securities Inc., as Co-Syndication Agents, and the lenders and issuing lenders from time to time party thereto, as amended through the date hereof.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7bbe21cc04c14276ac085032a0fe0db8">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">7.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Indenture dated as of May 22, 2017, between Martin Marietta Materials, Inc. and Regions Bank, as trustee (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>2017
                  Base Indenture</u></font>&#8221;).</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za2b6670dc3f149579d48c266ca369b9f">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">8.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">First Supplemental Indenture to the 2017 Base Indenture dated as of May 22, 2017, between Martin Marietta Materials, Inc. and Regions Bank, as trustee.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8fd8537f25244205acceaec171691291">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">9.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Second Supplemental Indenture to the 2017 Base Indenture dated as of December 20, 2017, between Martin Marietta Materials, Inc. and Regions Bank, as trustee.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z42d1328345bb4703b329aad3bace5f9a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">10.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Third Supplemental Indenture to the 2017 Base Indenture dated as of March 16, 2020, between Martin Marietta Materials, Inc. and Regions Bank, as trustee.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">III-5</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Annex A</u></div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>Specified Disclosure Package</u></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Preliminary Prospectus relating to the Notes dated June [&#9679;], 2021.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Pricing Term Sheet dated June [&#9679;], 2021, filed pursuant to Rule 433 of
        the Securities Act.</font></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">III-6</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Annex B</u></div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Martin Marietta Materials, Inc.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">INVESTMENT COMPANY ACT CERTIFICATE</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">The undersigned hereby certifies as follows:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">1.&#160; I am the duly elected officer, holding the office specified below my signature of Martin Marietta Materials, Inc. (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Company</u></font>&#8221;), and am authorized to execute and deliver this Investment Company Act Certificate on behalf of the Company.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">2.&#160; I am executing this Certificate knowing that it will be relied upon by Cravath, Swaine &amp; Moore LLP in connection with its legal opinions to be
      delivered on the date hereof in connection with the Underwriting Agreement, dated as of June [&#9679;], 2021, among the Company and Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC, as
      representatives of the several Underwriters named in Schedule I thereto.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">3.&#160; (a) The Company:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">i.&#160; is not and does not hold itself out as being engaged primarily, and does not propose to engage primarily, in the business of investing, reinvesting
      or trading in Securities (as such term is defined in clause (b) of this paragraph 3);</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">ii.&#160; is not and does not propose to engage in the business of issuing Face-Amount Certificates of the Installment Type (as such term is defined in clause
      (b) of this paragraph 3), and has not been engaged in such business or have any such certificate outstanding; and</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">iii.&#160; is not engaged and does not propose to engage in the business of investing, reinvesting, owning, holding or trading in Securities, and does not own
      or propose to acquire Investment Securities (as such term is defined in clause (b) of this paragraph 3) having a value exceeding 40% of the value of its total assets, exclusive of Government Securities (as such term is defined in clause (b) of this
      paragraph 3) and cash items, on an unconsolidated basis.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(b) For purposes of clause (a), the following terms have the following meanings:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Face-Amount Certificate of the Installment Type</u></font>&#8221; means any certificate,
      investment contract, or other Security which represents an obligation on the part of its issuer to pay a stated or determinable sum or sums at a fixed or determinable date or dates more than twenty-four months after the date of issuance, in
      consideration of the payment of periodic installments of a stated or determinable amount.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Government Security</u></font>&#8221; means any Security issued or guaranteed as to
      principal or interest by the United States, or by a person controlled or supervised by and acting as an instrumentality of the Government of the United States pursuant to authority granted by the Congress of the United States; or any certificate of
      deposit for any of the foregoing.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">III-7</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Investment Securities</u></font>&#8221; includes all Securities except (A) Government
      Securities, (B) Securities issued by employees&#8217; securities companies and (C) Securities issued by majority-owned subsidiaries of the Company which are not themselves investment companies.&#160; In considering whether a majority-owned subsidiary is not an
      investment company for this purpose, it is understood that (i) the exemption under Rule 3(c)(1) of the Investment Company Act of 1940, as amended (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ICA</u></font>&#8221;), may not be
      relied upon (such exemption could be available to a company whose outstanding securities (other than short-term paper) are beneficially owned by fewer than 100 persons and which is not making and does not presently propose to make a public offering
      of its securities) and (ii) the exemption under Rule 3(c)(7) of the ICA may not be relied upon (such exemption could be available to a company (a) whose outstanding securities are owned exclusively by &#8220;qualified purchasers&#8221; (<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>i.e.</u></font>, a natural person, trust or company that, in addition to other qualifications, owns at least $5 million in investments) or, subject to certain conditions, whose outstanding securities are
      beneficially owned by both qualified purchasers and not more than 100 people who are not qualified purchasers and (b) which is not making and does not propose to make a public offering of its securities).</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Securities</u></font>&#8221; means any note, stock, treasury stock, bond, debenture,
      evidence of indebtedness, certificate of interest or participation in any profit-sharing agreement, collateral-trust certificate, preorganization certificate or subscription, transferable share, investment contract, voting-trust certificate,
      certificate of deposit for a security, fractional undivided interest in oil, gas, or other mineral rights, any put, call, straddle, option or privilege on any security (including a certificate of deposit) or on any group or index of securities
      (including any interest therein or based on the value thereof), or any put, call, straddle, option, or privilege entered into on a national securities exchange relating to foreign currency, or, in general, any interest or instrument commonly known as
      a &#8220;security&#8221;, or any certificate of interest or participation in, temporary or interim certificate for, receipt for, guarantee of, or warrant or right to subscribe to or purchase, any of the foregoing.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Signature page follows</font>]</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">III-8</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #bfbfbf; background-color: #bfbfbf;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the undersigned has signed this Investment Company Act Certificate as of the date first written above.</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" colspan="3" style="font-weight: bold;">MARTIN MARIETTA MATERIALS, INC.</td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" colspan="2">&#160;</td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" rowspan="1" style="width: 50%;">&#160;</td>
            <td valign="top" rowspan="1" style="width: 3%;">&#160;</td>
            <td valign="top" rowspan="1" colspan="2">&#160;</td>
            <td valign="top" rowspan="1" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
              </div>
            </td>
            <td valign="top" style="width: 3%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
            </td>
            <td valign="top" nowrap="nowrap" align="left" colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0);">&#160;<br>
            </td>
            <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 4%;">Name:</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 31%;"><font style="font-size: 10pt; font-family: 'Times New Roman';">James A. J. Nickolas</font></td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" style="width: 4%;">Title:</td>
            <td valign="top" style="width: 31%;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Senior Vice President and Chief Financial Officer</font></td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" colspan="2">&#160;</td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[Signature Page to Investment Company Act Certificate]<br>
      </div>
      <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">III-8</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">June [&#9679;], 2021</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Martin Marietta Materials, Inc.</u></font><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>$[&#9679;] Aggregate Principal Amount of [&#9679;]% Senior Notes due 2023</u></font></div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>$[&#9679;] Aggregate Principal Amount of [&#9679;]% Senior Notes due 2031</u></div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>$[&#9679;] Aggregate Principal Amount of [&#9679;]% Senior Notes due 2051</u></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ladies and Gentlemen:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">We have acted as counsel for Martin Marietta Materials, Inc., a North Carolina corporation (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Company</u></font>&#8221;), in connection with the purchase by the several Underwriters (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Underwriters</u></font>&#8221;) listed in Schedule I to the Underwriting Agreement dated
      June [&#9679;], 2021 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Underwriting Agreement</u></font>&#8221;), among the Company and Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Truist Securities, Inc., and Wells Fargo
      Securities, LLC, as representatives of the several Underwriters, with respect to the offering and sale of $[&#9679;] aggregate principal amount of the Company&#8217;s [&#9679;]% Senior Notes due 2023 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>2023











          Notes</u></font>&#8221;), $[&#9679;] aggregate principal amount of the Company&#8217;s [&#9679;]% Senior Notes due 2031 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>2031 Notes</u></font>&#8221;)&#160; and $[&#9679;] aggregate principal amount of the Company&#8217;s
      [&#9679;]% Senior Notes due 2051 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>2051 Notes</u></font>&#8221; and, together with the 2023 Notes and the 2031 Notes, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Notes</u></font>&#8221;)











      to be issued pursuant to an Indenture dated as of May 22, 2017 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Base Indenture</u></font>&#8221;), between the Company and Regions Bank (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Trustee</u></font>&#8221;), as amended and supplemented by the Fourth Supplemental Indenture dated as of June [&#9679;], 2021 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Fourth Supplemental Indenture</u></font>&#8221;
      and, together with the Base Indenture, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indenture</u></font>&#8221;), between the Company and the Trustee.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">In that capacity, we participated in conferences with certain officers of, and with the accountants and counsel for, the Company concerning the
      preparation of the Prospectus Supplement dated June [&#9679;], 2021 (together with the related Basic Prospectus (as defined herein), the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Prospectus</u></font>&#8221;), relating to the Notes,
      filed with the Securities and Exchange Commission (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Commission</u></font>&#8221;) pursuant to Rule 424(b)(5) of the General Rules and Regulations under the Securities Act of 1933, as
      amended (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Securities Act</u></font>&#8221;).&#160; The Prospectus was filed as part of the Registration Statement on Form S-3 (Registration No.&#160;333-238199) filed with the Commission on May
      12, 2020, for registration under the Securities Act of various securities of the Company, to be issued from time to time by the Company (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Registration Statement</u></font>&#8221;), which
      Registration Statement includes a prospectus dated May 12, 2020 (together with the documents incorporated therein by reference, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Basic Prospectus</u></font>&#8221;).&#160; The documents
      incorporated by reference in the Registration Statement, the Specified Disclosure Package (as defined herein) and the Prospectus were prepared and filed by the Company without our participation.&#160; For the purposes of this letter we have also reviewed
      the documents and other information described in Annex A to this letter (together, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Specified Disclosure Package</u></font>&#8221;).&#160; Our identification of information as part of the
      Specified Disclosure Package has been at your request and with your approval.&#160; Such identification is for the limited purpose of making the statements set forth in this letter and is not the expression of a view by us as to whether any such
      information has been or should have been conveyed to investors generally or to any particular investors at any particular time or in any particular manner.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">III-9</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">Although we have made certain inquiries and investigations in connection with the preparation of the Registration Statement, the Specified Disclosure
      Package and the Prospectus, the limitations inherent in the role of outside counsel are such that we cannot and do not assume responsibility for the accuracy or completeness of the statements made in the Registration Statement, the Specified
      Disclosure Package and the Prospectus, except insofar as such statements relate to us and except to the extent set forth in paragraph 1 of our opinion to you dated the date hereof.&#160; Subject to the foregoing, we confirm to you, on the basis of
      information gained in the course of the performance of the services rendered above, that the Registration Statement, at the time it was last amended or deemed to be amended, and the Prospectus, as of its date and as of the date hereof, appeared or
      appears on its face to be appropriately responsive in all material respects to the requirements of the Securities Act and the applicable rules and regulations thereunder, except that we do not express any view as to the financial statements and other
      information of an accounting or financial nature included therein.&#160; Furthermore, subject to the foregoing, we hereby advise you that our work in connection with this matter did not disclose any information that gave us reason to believe that:&#160;
      (i)&#160;the Registration Statement (insofar as relevant to the offering contemplated by the Prospectus), at the time it initially became effective, contained an untrue statement of a material fact or omitted to state a material fact required to be stated
      therein or necessary to make the statements therein not misleading, (ii)&#160;the Prospectus, as of its date or at the date hereof, included or includes, an untrue statement of a material fact or omitted or omits to state a material fact necessary in
      order to make the statements therein, in the light of the circumstances under which they were made, not misleading or (iii)&#160;the Specified Disclosure Package, considered together as of [&#9679;] [a.m.][p.m.] on June [&#9679;], 2021, included an untrue statement
      of a material fact or omitted to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, except that, in each case, we do not express any view as to the
      financial statements and other information of an accounting or financial nature included therein and the Statements of Eligibility (Form T-1) included as exhibits to the Registration Statement.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">III-10</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">We are furnishing this letter to you solely for your benefit in order to assist you in establishing appropriate defenses under applicable securities
      laws.&#160; This letter may not be relied upon by any other person (including by any person that acquires the Notes from you) or for any other purpose.&#160; It may not be used, circulated, quoted or otherwise referred to for any other purpose.</div>
    <div><br>
    </div>
    <div>&#160;</div>
    <div style="text-align: left; margin-left: 234pt; font-family: 'Times New Roman'; font-size: 10pt;"><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font>Very truly yours,</div>
    <div>&#160;</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Deutsche Bank Securities Inc.</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">J.P. Morgan Securities LLC</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Truist Securities, Inc.</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Wells Fargo Securities, LLC</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">and the several other Underwriters</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">listed on Schedule I to the Underwriting Agreement,</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o Deutsche Bank Securities Inc.</div>
    <div style="text-align: justify; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">60 Wall Street</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">New York, New York 10005</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o J.P. Morgan Securities LLC</div>
    <div style="text-align: justify; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">383 Madison Avenue</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">New York, New York 10179</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o Truist Securities, Inc.</div>
    <div style="text-align: justify; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">3333 Peachtree Road NE, 11<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Atlanta, Georgia 30326</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o Wells Fargo Securities, LLC</div>
    <div style="text-align: justify; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">550 South Tryon Street, 5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Charlotte, North Carolina 28202</div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">120A<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
        </font></font><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">III-11</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>Specified Disclosure Package</u></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Preliminary Prospectus relating to the Notes dated June [&#9679;], 2021.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Pricing Term Sheet dated June [&#9679;], 2021, filed pursuant to Rule 433 of
        the Securities Act.</font></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">III-12</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%IV-%%-->
    <div><br>
    </div>
    <div style="text-align: right;"><font style="font-weight: bold;">SCHEDULE IV&#160;&#160;&#160;&#160;&#160; </font><br>
    </div>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div style="text-align: right;"><img src="image00003.jpg"></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FORM OF OPINION OF NORTH CAROLINA COUNSEL FOR THE COMPANY</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">June [&#9679;], 2021</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Deutsche Bank Securities Inc.</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">J.P. Morgan Securities LLC</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Truist Securities, Inc.</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Wells Fargo Securities, LLC</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;as Representatives of the several Underwriters,</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o Deutsche Bank Securities Inc.</div>
    <div style="text-align: justify; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">60 Wall Street</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">New York, New York 10005</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o J.P. Morgan Securities LLC</div>
    <div style="text-align: justify; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">383 Madison Avenue</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">New York, New York 10179</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o Truist Securities, Inc.</div>
    <div style="text-align: justify; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">3333 Peachtree Road NE, 11<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Atlanta, Georgia 30326</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o Wells Fargo Securities, LLC</div>
    <div style="text-align: justify; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">550 South Tryon Street, 5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Charlotte, North Carolina 28202</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ladies and Gentlemen:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">We have acted as North Carolina counsel to Martin Marietta Materials, Inc., a North Carolina corporation (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Company</u></font>&#8221;), in connection with the sale of $[&#9679;] aggregate principal amount of the Company&#8217;s [&#9679;]% Senior Notes due 2023, $[&#9679;] aggregate principal amount of the Company&#8217;s [&#9679;]% Senior Notes due 2031 and $[&#9679;] aggregate
      principal amount of the Company&#8217;s [&#9679;]% Senior Notes due 2051 (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Securities</u></font>&#8221;) pursuant to an Underwriting Agreement dated June [&#9679;], 2021 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Underwriting Agreement</u></font>&#8221;) between the Company and Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC,, as
      representatives of the several underwriters listed on Schedule I of the Underwriting Agreement (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Underwriters</u></font>&#8221;).&#160; Terms defined in the Underwriting
      Agreement are used herein as therein defined.&#160; This opinion is being rendered to you at the request of our client pursuant to Section 7(d) of the Underwriting Agreement.&#160; A copy of this opinion letter is also being provided to Cravath, Swaine &amp;
      Moore LLP and Simpson Thacher &amp; Bartlett LLP with the understanding that each of those firms may rely upon this opinion letter in providing its opinion to you pursuant to, respectively, Sections 7(c) and 7(e) of the Underwriting Agreement.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">IV-1</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In such capacity, we have examined, among other things, (a) certified copies of the Restated Articles of Incorporation of the Company, as amended (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Articles of Incorporation</u></font>&#8221;), the Restated Bylaws of the Company (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Bylaws</u></font>&#8221;), and resolutions of
      the Finance Committee of the Board of Directors of the Company, resolutions of the Board of Directors of the Company, resolutions of the Chairman of the Finance Committee of the Board of Directors of the Company, and resolutions of the Chairman of
      the Board of Directors, President and Chief Executive Officer of the Company and the Senior Vice President and Chief Financial Officer of the Company, (b) executed copies of the global certificates representing the Securities, (c) an executed copy of
      the Indenture dated as of May 22, 2017 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Base Indenture</u></font>&#8221;) between the Company and Regions Bank, as Trustee (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Trustee</u></font>&#8221;), an executed copy of the First Supplemental Indenture dated as of May 22, 2017 between the Company and the Trustee (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>First Supplemental Indenture</u></font>&#8221;),











      an executed copy of the Second Supplemental Indenture dated as of December 20, 2017 between the Company and the Trustee (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Second Supplemental Indenture</u></font>&#8221;), an executed
      copy of the Third Supplemental Indenture dated as of March 16, 2020 between the Company and the Trustee (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Third Supplemental Indenture</u></font>&#8221;), an executed copy of the Fourth
      Supplemental Indenture dated as of June [&#9679;], 2021 between the Company and the Trustee (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Fourth Supplemental Indenture</u></font>&#8221;; the Base Indenture as supplemented by the First
      Supplemental Indenture, the Second Supplemental Indenture, the Third Supplemental Indenture and the Fourth Supplemental Indenture being referred to herein as the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indenture</u></font>&#8221;),











      (d) an executed copy of the Underwriting Agreement (the Underwriting Agreement together with the Base Indenture and the Fourth Supplemental Indenture, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Transaction Documents</u></font>&#8221;),











      (e) the Company&#8217;s Registration Statement on Form S-3 filed with the Securities and Exchange Commission (Registration No. 333-238199) (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Registration Statement</u></font>&#8221;), (f) the
      prospectus, dated May 12, 2020 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Base Prospectus</u></font>&#8221;) relating to the offering of securities of the Company, which forms a part of and is included in the Registration
      Statement, (g) the Preliminary Prospectus Supplement dated June [&#9679;], 2021 with respect to the offering of the Securities (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Preliminary Prospectus Supplement</u></font>&#8221;) and the
      Pricing Term Sheet dated June [&#9679;], 2021 with respect to the offering of the Securities (together with the Preliminary Prospectus Supplement, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Pricing Disclosure Package</u></font>&#8221;),











      (h) the Prospectus Supplement dated June [&#9679;], 2021 with respect to the offering of the Securities (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Final Prospectus Supplement</u></font>&#8221;), and (i) such other documents,
      corporate records, certificates and instruments as in our judgment are necessary or appropriate to render the opinions expressed below.&#160; References to the &#8220;Base Prospectus,&#8221; &#8220;Preliminary Prospectus Supplement&#8221; and the &#8220;Final Prospectus Supplement&#8221;
      include the documents incorporated or deemed incorporated by reference therein.&#160; As to various factual matters, we have relied upon certificates of public officials, certificates and statements of officers of the Company, and such other documents and
      information as we have deemed necessary or appropriate to enable us to render the opinion expressed below, and we have not undertaken any other investigation to determine the existence or absence of any such facts.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In giving the opinions expressed herein, we have assumed:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">(i) the legal capacity of all natural persons executing
        agreements, instruments or documents, (ii) the genuineness of all signatures, (iii) the authenticity of all documents presented to us as originals, (iv) the conformity to the originals of all documents presented to us as copies, (v) the integrity
        and completeness of the records of the Company to the date hereof and (vi) the absence of fraud, duress, or mistake; and</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">that each of the Base Indenture and the Fourth
        Supplemental Indenture has been duly executed and delivered by the Trustee.</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">IV-2</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Upon the basis of such examination, and subject to the limitations and qualifications expressed herein, we are of the opinion that:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company is a corporation duly incorporated and
        validly existing under the laws of the State of North Carolina, with corporate power and authority to own its properties and conduct its business as described in the Base Prospectus, the Pricing Disclosure Package and the Final Prospectus
        Supplement.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company has the corporate power and authority to
        execute and deliver each of the Securities and the Transaction Documents and to perform its obligations thereunder; and all corporate action required to be taken for the due and proper authorization, execution and delivery of each of the Securities
        and the Transaction Documents and the consummation of the transactions contemplated thereby has been duly and validly taken.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(3)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Each of the Base Indenture and the Fourth Supplemental
        Indenture has been duly authorized, executed and delivered by the Company.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(4)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Securities have been duly authorized, executed and
        delivered by the Company and, when duly authenticated as provided in the Indenture and paid for as provided in the Underwriting Agreement, will be duly and validly issued and outstanding.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(5)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Underwriting Agreement has been duly authorized,
        executed and delivered by the Company.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(6)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The execution, delivery and performance by the Company
        of each of the Securities and the Transaction Documents, the issuance and sale of the Securities and compliance by the Company with the terms thereof and the consummation of the transactions contemplated by the Transaction Documents will not (i)
        result in any violation of the provisions of the Articles of Incorporation or Bylaws or (ii) result in the violation of (x) any North Carolina law, statute, regulation or rule or (y) any North Carolina judgment, decree or order of which we are
        aware.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(7)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">No approval, authorization or consent of any North
        Carolina governmental authority or agency is required under any North Carolina statute, rule or regulation in connection with the authorization, execution, delivery or performance by the Company of each of the Securities or the Transaction
        Documents, the issuance or sale of the Securities or the consummation of the transactions contemplated by the Transaction Documents, except those which have already been obtained, if any.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The opinions set forth herein are limited to matters governed by the laws of the State of North Carolina and the federal laws of the United States, and
      no opinion is expressed herein as to the laws of any other jurisdiction.&#160; We express no opinion concerning any matter respecting or affected by any laws other than laws that a lawyer in North Carolina exercising customary professional diligence would
      reasonably recognize as being applicable to the Company, the execution, delivery and performance by the Company of the Transaction Documents, the issuance and sale of the Securities and compliance by the Company with the terms thereof and the
      consummation of the transactions contemplated by the Transaction Documents.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">IV-3</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This opinion is being provided solely to you and Cravath, Swaine &amp; Moore LLP and Simpson Thacher &amp; Bartlett LLP in connection with the
      Underwriting Agreement, may not be relied upon by you or Cravath, Swaine &amp; Moore LLP or Simpson Thacher &amp; Bartlett LLP for any other purpose and may not be relied upon by any other person for any purpose.&#160; This opinion letter is limited to
      the matters stated herein and no opinion is implied or may be inferred beyond the matters expressly stated herein.&#160; This letter speaks only as of the date hereof and is limited to current statutes, regulations and administrative and judicial
      interpretations.&#160; We undertake no responsibility to update or supplement this letter after the date hereof.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc6ebe0e986764391a962475514210c87">

        <tr>
          <td style="width: 46%; vertical-align: top;">&#160;</td>
          <td style="width: 54%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Very truly yours,</div>
            <div>&#160;</div>
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ROBINSON, BRADSHAW &amp; HINSON, P.A.</div>
            <div>&#160;</div>
            <div>&#160;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z63f5faa7bf754fa8a469822691a141d6">

        <tr>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">cc:</div>
          </td>
          <td style="width: 95%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Cravath, Swaine &amp; Moore LLP</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 95%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Simpson Thacher &amp; Bartlett LLP</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
  </div>
  <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">IV-4</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99-1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Cravath, Swaine & Moore LLP
         Document created using EDGARfilings PROfile 7.5.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div> <img src="image0.jpg"></div>
  <div><br>
    <div style="font-size: 14pt; font-family: Arial; font-weight: bold;">Martin Marietta Announces Pricing Terms of Debt Offering</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">June 21, 2021</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Raleigh, N.C., June 21, 2021 (GLOBE NEWSWIRE)<font style="font-size: 10pt; font-family: Arial; font-weight: bold;">&#160;</font>&#8211; Martin Marietta Materials, Inc. (NYSE:MLM) (&#8220;Martin
      Marietta&#8221; or the &#8220;Company&#8221;)<font style="font-size: 10pt; font-family: Arial; font-weight: bold;">&#160;</font>announced today the pricing of its offering of $700 million aggregate principal amount of 0.650% Senior Notes due 2023 (the &#8220;2023 Notes&#8221;), $900
      million aggregate principal amount of 2.400% Senior Notes due 2031 (the &#8220;2031 Notes&#8221;) and $900 million aggregate principal amount of 3.200% Senior Notes due 2051 (the &#8220;2051 Notes&#8221; and, together with the 2023 Notes and the 2031 Notes, the &#8220;Notes&#8221;).&#160;
      The 2023 Notes will mature on July 15, 2023, will have an interest rate of 0.650% per annum and will be issued at 99.988% of par value. &#160;The 2031 Notes will mature on July 15, 2031, will have an interest rate of 2.400% per annum and will be issued at
      99.937% of par value. &#160;The 2051 Notes will mature on July 15, 2051, will have an interest rate of 3.200% per annum and will be issued at 99.197% of par value. &#160;Interest on each series of Notes will be paid semiannually on January 15 and July 15,
      commencing January 15, 2022.&#160; The Notes will be sold pursuant to Martin Marietta&#8217;s shelf registration statement, base prospectus and prospectus supplement on file with the Securities and Exchange Commission (&#8220;SEC&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">The net proceeds of the 2031 Notes and the 2051 Notes are expected to be used, together with cash on hand, to pay the consideration for the Company&#8217;s previously announced
      acquisition of the Lehigh West Region Business (the &#8220;Acquisition&#8221;) and to pay related fees and expenses. The net proceeds of the 2023 Notes are expected to be used for general corporate purposes, which may include funding acquisitions (including
      without limitation the Acquisition) or repaying indebtedness.&#160; Closing of the offering is expected to occur on July 2, 2021, subject to the satisfaction of customary closing conditions.</div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC will serve as underwriters and joint book-running managers for the
      offering.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Martin Marietta has filed a shelf registration statement on Form S-3 (including a base prospectus) with the SEC for the offering to which this communication relates.&#160; Before you
      invest, you should read the prospectus in that registration statement and the prospectus supplement thereto and the other documents that Martin Marietta has filed or will file with the SEC for more complete information about Martin Marietta and this
      offering.&#160; The offering will be made only pursuant to the terms of the relevant prospectus supplement (including the prospectus).&#160; These documents will be available at no charge by visiting EDGAR on the SEC website at&#160;<u><font style="font-size: 10pt; font-family: Arial;">www.sec.gov</font></u>.&#160; Alternatively, these documents will be made available upon request to any underwriter participating in the offering.&#160; Interested parties may obtain a prospectus and the related prospectus supplement
      from Deutsche Bank Securities Inc., 60 Wall Street, New York, New York 10005, Attn: Prospectus Group by telephone at (800) 503-4611 or by email at <font style="font-size: 10pt; font-family: Arial;"><u>prospectus.CPDG@db.com</u></font>; J.P. Morgan
      Securities LLC, 383 Madison Avenue, New York, New York 10179, Attn:&#160; Investment Grade Syndicate Desk&#8212;3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup> Floor or by telephone at (212) 834-4533; Truist Securities, Inc., 303 Peachtree Street, Atlanta, Georgia 30308, Attention: Prospectus
      Dept or by telephone at (<font style="font-size: 10pt; font-family: Arial;">800) 685-4786</font>; and Wells Fargo Securities, LLC, 608 2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup> Avenue South, Suite 1000, Minneapolis, MN 55402, Attention: WFS Customer Service by telephone at
      (800) 645-3751 or by email at&#160;<font style="font-size: 10pt; font-family: Arial;">wfscustomerservice@wellsfargo.com</font>.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities.&#160; Offers of securities will be made only by means of a prospectus filed
      with the SEC.&#160; The prospectus is part of a shelf registration statement that has become effective under the Securities Act of 1933, as amended.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt; font-weight: bold;">Company Description</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Martin Marietta, a member of the S&amp;P 500 Index, is an American-based company and a leading supplier of building materials, including aggregates, cement, ready mixed concrete and
      asphalt. Through a network of operations spanning 26 states, Canada and the Bahamas, dedicated Martin Marietta teams supply the resources for building the solid foundations on which our communities thrive. Martin Marietta&#8217;s Magnesia Specialties
      business produces high-purity magnesia and dolomitic lime products used worldwide in environmental, industrial, agricultural and specialty applications.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Investor Contact:</div>
    </div>
    <div>
      <div style="text-align: left; color: #007DC6; font-family: Arial; font-size: 10pt;">Suzanne Osberg</div>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">Vice President, Investor Relations</div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">(919) 783-4691<font style="font-size: 10pt; font-family: Arial;"><br>
      </font><u><font style="font-size: 10pt; font-family: Arial;">Suzanne.Osberg@martinmarietta.com</font></u></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">MLM-G</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt; font-weight: bold;">Cautionary Statement About Forward-Looking Statements</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Investors are cautioned that all statements in this release that relate to the future involve risks and uncertainties, and are based on assumptions that the Company believes in good
      faith are reasonable but which may be materially different from actual results. These statements, which are forward-looking statements under the Private Securities Litigation Reform Act of 1995, give the investor the Company&#8217;s expectations or
      forecasts of future events. You can identify these statements by the fact that they do not relate only to historical or current facts. They may use words such as &#8220;guidance&#8221;, &#8220;anticipate&#8221;, &#8220;expect&#8221;, &#8220;should&#8221;, &#8220;believe&#8221;, &#8220;will&#8221;, and other words of
      similar meaning in connection with future events or future operating or financial performance. Any or all of our forward-looking statements here and in other publications may turn out to be wrong.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Statements and assumptions on future revenues, income and cash flows, performance, economic trends, the outcome of litigation, regulatory compliance and environmental remediation
      cost estimates are examples of forward-looking statements.&#160; Numerous factors could affect our forward-looking statements and actual performance.&#160; In addition, other risks and uncertainties not presently known to us or that we currently consider
      immaterial could affect the accuracy of our forward-looking statements.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Except as required by law, we undertake no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this
      press release.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">You should consider these forward-looking statements in light of risk factors discussed in the preliminary prospectus supplement filed with the SEC on June 21, 2021 and those in our
      Annual Report on Form 10-K for the year ended December 31, 2020 and other periodic filings made with the SEC. All of our forward-looking statements should be considered in light of these factors. In addition, other risks and uncertainties not
      presently known to us or that we consider immaterial could affect the accuracy of our forward-looking statements, or adversely affect or be material to the Company. The Company assumes no obligation to update any such forward-looking statements.</div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>mlm-20210621.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://martinmarietta.com/20210621" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:mlm="http://martinmarietta.com/20210621" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2021">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="mlm-20210621_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="mlm-20210621_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://martinmarietta.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>mlm-20210621_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>mlm-20210621_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://martinmarietta.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="mlm-20210621.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://martinmarietta.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !. +\# 2(  A$! Q$!_\0
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MCC<?=@/7_OK^6*\Y\7>')/#&ORV1W&V?]Y;2'^)#V^HZ'\^]?1P 50J@  8
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K %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image00003.jpg
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !3 )@# 2(  A$! Q$!_\0
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M2.ENT<C-%<E/O!6('(R./0U>^'NDWUA;:IJ.KQ+!?ZK=M>/;JV[R5P J9[G
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@0 4444 %%%% !1110 E%%% "T444 %%%% !1113 _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>form8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mlm-20210621.xsd" xlink:type="simple"/>
    <context id="c20210621to20210621">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000916076</identifier>
        </entity>
        <period>
            <startDate>2021-06-21</startDate>
            <endDate>2021-06-21</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20210621to20210621"
      id="Fact_a5a6f7f313f74a7781882fd35c312f73">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20210621to20210621"
      id="Fact_e8f5621b6ff54d96ab7c123ad8272a21">0000916076</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20210621to20210621"
      id="Fact_b655bc540e404adeb186ba793d7f976a">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20210621to20210621"
      id="Fact_ae78e677515143f8987189a45557814e">2021-06-21</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20210621to20210621"
      id="Fact_4c70cb0d6304471783f50bf01b8db12a">Martin Marietta Materials, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20210621to20210621"
      id="Fact_ec44c07b11a04d8baf2c7c01effc55da">NC</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20210621to20210621"
      id="Fact_865f1523ca2b4bc1bb0fefe975f71edd">1-12744</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20210621to20210621"
      id="Fact_64dfb24c845343ec8a1596f590fa171f">56-1848578</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20210621to20210621"
      id="Fact_032cbe1b472542449731c32179994a71">4123 Parklane Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20210621to20210621"
      id="Fact_a287e99ca14d45b29187f8e3a0128938">Raleigh</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20210621to20210621"
      id="Fact_71b076190ca24305b343d820827c61f9">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20210621to20210621"
      id="Fact_37dd35238db344ab90c03d1570152d4b">27612</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20210621to20210621"
      id="Fact_6de7c025612e49bea7962868495c7122">919</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20210621to20210621"
      id="Fact_9cd53bdcc7994dd9aee0f8a321d4adc4">781-4550</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20210621to20210621"
      id="Fact_3625bd4c2b43405fa9fbaa928afcf7e6">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20210621to20210621"
      id="Fact_6ec78d9c0eda494ca600bcbb38c87011">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20210621to20210621"
      id="Fact_13c3650191594f2b866f1174b84412c0">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20210621to20210621"
      id="Fact_0e44f75ec66442579ce354f91c7f71b1">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20210621to20210621"
      id="Fact_f499cc222b144d729d40669849330a69">Common Stock, $.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20210621to20210621"
      id="Fact_07359535fd6844b6b9b184ddedcf1a4b">MLM</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20210621to20210621"
      id="Fact_958f6384db5745318da8826c013216a5">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20210621to20210621"
      id="Fact_21a6beb7c435490094cbc99833200a9b">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139992113729976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 21, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 21,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Martin Marietta Materials, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-12744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-1848578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4123 Parklane Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Raleigh<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">27612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">781-4550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000916076<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MLM<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M1];#C=5I<4Q<:@N'SJ*X@6.^,*X"O%]I;=]OW,FS_.%@] ]02P,$%     @
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M-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @
M0('64@=!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " ! @=92]3W06NX    K @  $0
M@ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " ! @=92F5R<(Q &
M  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+
M 0(4 Q0    ( $"!UE*8)^VQ+@0  $00   8              " @0T(  !X
M;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " ! @=92GZ ;\+$"
M  #B#   #0              @ %Q#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( $"!UE*7BKL<P    !,"   +              "  4T/  !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( $"!UE(<.&7J/P$  #P"   /              "
M 380  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " ! @=92)!Z;HJT   #X
M 0  &@              @ &B$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " ! @=9299!YDAD!  #/ P  $P              @ &'
L$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #1$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://martinmarietta.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8k.htm">form8k.htm</File>
    <File>ex1-1.htm</File>
    <File>ex99-1.htm</File>
    <File>mlm-20210621.xsd</File>
    <File>mlm-20210621_lab.xml</File>
    <File>mlm-20210621_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mlm-20210621_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mlm-20210621_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mlm-20210621.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "mlm",
   "nsuri": "http://martinmarietta.com/20210621",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8k.htm",
      "contextRef": "c20210621to20210621",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://martinmarietta.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8k.htm",
      "contextRef": "c20210621to20210621",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://martinmarietta.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000950157-21-000681-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950157-21-000681-xbrl.zip
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M48C?I/G7)/5?U5PRYWT?N^F[-9<V44J.4AYNHI1K&7D<K(GMK:ZLJF@+%:
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M14 ;'DZETA%_N\#<F/,FRW._M$<K\O55_+!'>$6PLK#UFKE>=D;DFP]9#]=
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M..")'6^RX&;M#+MII%)I&J(+O28%"8=BKY>P[K=.M%G5;H!QD0)5RFO%/_1
M\ V3JKT_=HUCS"GV8PJJ13?8 ._6(?EWDPCH@U8Z.CDASS,5X%0#/Z5B=A,[
MU$Y@+\H^%_6DZD]1U)=Y"C(+?RYB&K\B$320UG@Y@$OJL7::# E41((L&K06
MX"/X:B[&PLHM5@5VQJP/QYG $TM1:<HI%#TA/&J@8Y7^$ C=E-TY"@:8(0$#
ML#&*V(8+Z..H!P7L(5 .#*FF\/.(2,A+0J4>Y66K1X5\/U>'SK$)C@(@6ZU6
MDF^<2G8JCS9.Y5HZE7_\5<R";G/ Z&W2V$;YN?[KPOJZZ3.9-WEZQ4*?AF>
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M6Z?ET4W69GI[&:-D#H]^'=:TNJQ7I7(VT7R.YK_81//7,IJ?K8G]$H'.1Y/
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M<S8>%MAZ,ZL69X:J8IK8L42<]VRE7ZU!A53P,<DKCA-3(+V<8.<?<@DCC!D
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MY78XW3E))K1N,E^\YV:;"O<Z0&)P3*)L:OD?G DYV61"UC(3\F4-?.-KR^-
M(833WU,0 U0E/!%8-ZSB07$P03XQT I*C[A3(1<TV]B$+A_#9?A^2QFGZ\$Q
M^D"PK91L\ S47R05B1SH&B-"A4K6 T5I("M9%DGYF8*2B0VZ855;B3WFGTVF
M BZW$8+$Y<W19NMU7/]8@^-Z[(K"9?QINY-EJJN0X/1&28]0<*Q>$/(&:Y8-
M5M6SY5.F<250D0559*%<&A31'9KE^B7>T"YZ7A+V&((7CX-3602IVJ(TRK2
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MG9'/NJ@1'7%1K+;-I:Q78J1SH#$<.E/AI$MH0P.DN(\ >K2FI247&.1A]&C
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M]?.@SS@UZ2[2 =U*S%@C5IBQ4\D"4D_EBGENRZ.;OT+F#.@W"14<_10<OEB
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MKYKH.:1EPUG%QC-N@5 5XW>CF*O\0916.P:0V/BG,SU[4V/,;$M=E#BIH;3
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MHXT&0HRS2@B$C%:%JDNA$&WF:?G4 -G1("-J=&9'C<[YFU]/+V4PUT,LK<?
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MN)3J<0P!/*+#,N?,8JQZ<Q<SV,7Z<:V4&9 VJKW-ZMT#RV(G'^Y,\O[GN+)
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MWFBU">Q-A&W,YT228 I%*:3266PSRE/L.Z)B8RLR@G [I6Z'!K'$?L8P&=1
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M7">;L_"X<LJE:.6$H3PX2:3,0I7R]#12:6%]0ZLB21.J>M8245?(*D=T(Q"
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M;!(E)J4:8'\[UM/'7U0BM<T%FCWA-68A&Q6PMBK@330-SNAZG^79+;;';'3
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M]@<XM=YP]&,1IC) UJ"?I9^>VS[E UD4(P+"*#]S@X[ 98!NZ*3XM]BLZLO
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M,'21&P$@\;W(EZC"A%9F]0I;V&50@ 65:N1(+BH9%%9.X$1(68_".Z5 38(
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M7*C9<8&; L+@1Z,T]DBXTO0A8V*/9NK%X0W5-G'&]0L63AG_WV>1[).@6/O
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M    " ! @=92SBVQ&@T.  "+*P  "@   &5X.3DM,2YH=&W%6FMOVS@6_;[
M_@=N.M-I -NUX[R3!I-7BYE-VB NMNA'6J)M-I*H(2D[GE^_Y_(AR\YSNIUL
M"C2.)(KWGGONDSZ<V#P[^N<_&#N<")ZZ3_ALI<W$T>%;_SM<_%>[S2YD(@HC
M4F;5/CO5?,KMI,4&,RX+P5ZS2Z6T8!<75WZ)^SE3296+PK)$"VZQM#*R&+/S
MLP_'UR.9X;-A5]>?\%&PG<Y6I]OI-E:?JG*NY7AB66]O;XNUV49WH\=.M.*I
MENE8L';;B_\VR'\X5.F<#<>)RI1^M_9JY'[6F+'S3+Q;&ZG"MD<\E]E\G_WR
M6>;"L(]BQJY5SHM?#IB[;^2?8I_UNJ4]8%;<VC;/Y+C89YD8X8I[\SY[U74_
M!VM^_U1.XQ[-)4YV/'-(+UX28B;HUCX;JBS% ^>W$SF4ENWM=7J';^F)H\.A
M#KKAY?4N1^Q0YF-F=/)N3>9\++J=;^48.RP_%1<OB]94;Y/46\+C6$N>A6LK
MXEUR;67!\$L*:SD[+@I5%0G0N](R(8-^%CHW3(W8F1A:]FDT$AJ7%U+=E6OE
MUGWP?:N,E:/Y(W(V;+5V]'L%&F[T6HXE+[OU-<\(L1;[V#GMM-B2).S-AXM/
M)^?LX_F7P9??KL_7[[*A2;GGVN3UJ]YV]R"0Y?6KW8U>[X"M&NH2/D>O,"WV
M6Y%TV)N/7P?G^Y<7E^OL#:W9Z![X)='IXDIW$R]4FMD)G-L_>ZKRDA?S<//O
M4(0'9E&,2?G<;5X&CH%=TA+)/+GH[Y]VNEV&'3*I"L;'8RW&T)A6%(DL><9X
MCM=9>K3;V=[J_LP&HI!0ZJ.R8&]:"3)1G[UI*.DNN/M1SQ;[::];QZ7G;;?1
MV>S>OUV_M[(=+BQMQWB1NAV?N56_L_' 5ENK6VTM;T4[M8#T6. IS6;23ASB
M"PB<+/Y2%+/59,22X!UOR@C4Y^4WS: ,R[FMD"2@T^]5-F>]+><C_9:_.^%3
M@1V9+$!;82S3I//">"6$!$.JW(GEE@P%D\94( QWX7-O=_=G6E%RS:8\JT2'
M>:D^+RGQB#3]WE/2!-L^(4V$@83J[SPFU-;30FT]*51@P3,@ZNT](,UO\9W8
M6_!DP@P<3;BPWI /KRNY3'$SE[03SR E2<OQ69/ ;NLH?(0A43D* >?(BR>=
M]3<";QQAEC<R"!&LK+2I.+ANU6J <W%OY\ P,Q'9B,%)I+% A)S&6"!#M4>+
M#;DAUU&F%(FM/*D;?YJJ+#/W*.GA:I':%08BJ;2T,KC"^6TRX04J#X3"'*C2
M1C&2#LY/:T]XV?1#P!7"DDZ)$*FSV++3-ORX9AL'R\0M8>#"+>%=H;I;#0@)
M-Q/"91*"!:SOXW*B"B-3$> >A531R!'.,J464ZDJ S;4P3UR@B=_5-)(MSZ(
M?"$FR [L"]'P&N;$G1.J&84Q2['L>+%T*6X&^;3(7+DY$D%W4A2UJ^FPA\%:
M!+W[D7$ZCD4!E3-HKTOEG _\+)6AP#B;2'A-COT1I;,J%6Q4%2E1OJ$I]/!W
M<3T"04"KRK),YM)Z/$FDAI+KE(JU@&[T.EFDJ+-$2K!$[SG-E EID=;6:5*:
M)5U4 D+7T67#UR@M^,#P&YZA)VBU@1!FQ)-HF@2$1)$,ITW"-K!^ZO6Y0_8?
MP&CVM_K+F:BL2:#F"2]NFBY.11+*M\Y5!]V,'B/.-FY>7)RVV&<-B]C&Y5!9
M$<>^B"PS[#W78[7T !;ZB(9X2M';,+!"Z!GN"^WI^4TAH*,B4C=M714% 8R6
M!/4][@?/BER)AGWA&+-:6DZ@!H5*9)5'HR]1[;W2.1NT^PWF8]5*5%YO!-WS
MTSJ>U#P&,[U_V0DH3>FD*F3B=_/N7KO"B1A1*SI7501-%E-$E!9=@K2J0EI!
M0YJ&^K+.!)+\#EGR 55B$+T_=U#(%) R/J5<#$U#!VS\FQ^&46E/DI7\$Z#(
M22$HC<T0<F2!:[D7CP\I<JR^UPLAS1W6-')M#6U,MSE/J?! 7&CF7!+#QOZ.
M_@#:8DHW[\>A8>1EL-8;F\/T"V3B_GS*9<:'T!](%8HAUVKDVN&<35T8C),#
M%N(C@3,30]RB%:&1J.YIMY_H2]:.9K-9QXBD,U;3V'^_K8ZBO,<9]"\ ]U1D
M<U?_WBN^@V^A0U4Z9OY142YSO)@W'9_J+RNIF+<^I"_1/6X=:S(0Q#V/.$3Y
M10TMQPJ^6M4$\[C<=Z]U(A]&6N7LB3BXW65?4-VQ@=5"P'EH5/)5Z9O%)T#:
M[:**.[86$>5JL>$'K:J2#&?!E7*B"F?2-[O=[CK;ZO;;F]N]'C$>3X@<@-'=
M[S ;C+W0LG-Z=?;AUW38@9N0]8(A#YKQ/*J_&M;[NWWX3BH-3'8\%44E'E"W
MM[,7U*T-1)'%$?^#)@(,YDB,"14&9\+<N#IHXZ!_"!-$W::"#,^S&(E=5+:J
M/$#^+T1[$OKCWE(8-CE,(324UNGA6[SMB+W/%"#T*"[CC"W7V6Y_L[VYU>\?
M/)2TH':WSZZHU"<+UW8^MAF\F[?8!P'0)*?'NKM.;:B)F-,T=43T3)3V7EF^
MPZR.)MN[6^W-G=WMVHQ/I%CBZR[;^(% %Q%HSP@V0*"E@6=%\8:8WV*7LB@$
M+U4F(<3E1[:UM=G=6$+JR_L!.W75$UQ^@ ) )F(5I(BA]X_MS:UV?V=KU3]"
M>/N.V#8R21# ^/U_G1&,(T+1.XM#^,6;%NFZ Q3VE%"X"ZGPQT)9UUI8:2OK
M>ET7$RF"&HA-J'!J#!$Z0ZF,M-1\:EC-7:PU-3]B,'5S29?&%O?N27X /1>\
M< \N15B7J)LU>\Q"S:S:+">,"]K^/8\62:XVH%I@*& 0=!^0-*%\XS/&:BMZ
MG+B7]O;Z_1;5DQPO247ZHA:\=Y@7NC\*?8F6)6GY?RU3@0YLF0\!82A>!J]Y
M7AY<(0MU$013<=LB,X$_Q_ /!(NB375IZFHMTH2B#F?@IRMH7"*5_FW#2F:I
MK]3K*6NCOHTS.UQ-PAR"2DYP2]ZZ]Q>)%H[@BW[8E!.>6>I1D3_1!G/J5&>4
M>;"?*D.OC7P.T5R3L+'M281-3M$OI+RN D[XA.<<U\$+EX[2.S6B%3P/M<$\
M5 Y&59KF^E1RUOJYAA .1PTPZ!AD ']]/8XEL1QWY+03#>)V'IS57/(Q^E:D
ME0'<!+#1HHC ,/;Z\**T(DEH'- NB?A +JXD)5.5*73+,J&N680%J,9<IP[,
MLG0F4RJ5F2BF4JN";, SLE$*3I'!P(XQ;%YEMJ*6GMYJ@DPP/%G:]Q=W6]QG
MD#@!9S0YAIT<0'(DTH)R3_2>< 6W$9DC?9E,WZV=#:[>7Z'U.P%=;H[QW]I1
MA*?Y_A*/M(?T3)N/0,!]GLWXW-SWDL4+Z*A/(\2:":+=N[7PH3X@\T+ML\WR
MEG7+VP,$N=1.2+KNSP=012,6M<,UA+N80#?HT7@R=O*>_N%IGMR,-1&FO7JK
M"4WS[.HNF(_@?"\H_T/D\(4<>'^*6SRQ^X_*]=3FJZ>%.V>GV\^59%#]"?<6
M[)-!W!H_)L;#.S]OI_]0,7(%MX>G4("J,;BF'H*8_Z-W?+/7VUMG.[O4 NSU
MOJ?DKPE!</A6[;M:OH!RQZ/\:^ZB51Z"5:,L\JW$B^:PB\OVA[_B"2^>Y7E%
MY*!QX* N88[='.*]TC.NT_:%4C>4.^K[=YCT]V(8F>R'N8D7F":@5&A14UO7
M7F'J(Q=E:!@!41<=YQ^CRAW*R&*J,A1E6IH;WW#3/%M3+^[[$%<MX$%?0]!T
MQI@J+WW&=.]MS,A1[*&6@)PDP5BIN@X8<:HMZ3V(WFA)W3AA"'07 V97L/JR
M \D[E539DA5<7X_H52&?P:^1VOS(&VHM-(Z3:MIA% R6!8,U<%F4GE?(Z(1&
MLVW&K[$O8Z]IW)8OBM*]K18;4^U*2V4,*?<=#OC!="PH=*V_TB+AQAWV1NB!
M4T&Z?%45S%DP%[% B#"-:8@]],4,3:]KR &1<IU%,*NK\V%;F!VR48](?064
M\R!BJ8=M[L!&24$514K%$L%FXBG$N)(I!P/"$40K7D?[["<[=^YXC5>O^I'D
MZM5 C]7+U+#4UXAP?M#H!52C"**1<!&N72L3!DRH.0OA9_JN>UF"E@ (%T*E
M28<)N"8+J B>T=FB&SM"X0X[!G^I%:..;.1JP$>81)-1)RJ$\-*6U;"NKAS&
MV!CW*AO.6V8HV%YZQ+V(5=Z/&ZY+!UP>&RW<,,#7^M2JT:/NC&R4J1DN-U!J
M,71S!:K4A%D0*PUGY]#2K01N6>U%U!V,*Y!3T2$+#7HEO<(?7C4+6#R7HZ1W
MBQ:'J\8RN)FDF!#/KS@-B[T+/6B9V+A^K-#]*&IQ07V*FHF;D7/7ACYE70>6
M#SE-BM0#,L93?U34"L9_('PZ!Z6) -X*][PIU*P@.E3&?P\%KCP3T4FS>7T
M60_Y\Q@2E\4GS#D=>_%D_C197YATY[<)3<ZX<:-BJ9$V$, R/FN1LBX$6WXC
M:!RNX#(AY!(J9<I=^SA_S#;D<#KU@Q$M1AGA04N<S[N8)W52Y5A!9',8DS>B
M#$+,<WV%@R\-WS)H'BDLS6Y>&+6OBW.<R(*0"!['(G/?)H0B1,&:[*FD"1EE
M[#"%AVIT%.LJG/L/.?R9S=(QC3M3;7[QR[?BRK@F%*2+P!V[;TT@;99*+\['
M>MWVO^M3KSD:).9F.NQ,)'Z T??O[39B/MQ-*K3W+'Z7T@VQEB93[/A9$3J
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M[J&KWPS;*8^,BQ2&6?V:U]I0SC[O]M5O(._IGT7.QS%\^#]02P,$%     @
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M7PZ5Y\I\%W1(TRO?%5V5O,VR[?U@>4G2:TC;EZ40^YC*R2[^ 5!+ P04
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M[!?P&KM*WK+^,O#F' %^E6OG!7"9)&M,:Y>!40X7 R!W5Q*:>4N%8>JG9GG
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M"D<H4"Y!A:8/M6+?6_*F38!J TR2:\+BVU4MG 8!8S I_KD*8SP&*\&BD^H
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M2P$"% ,4    " ! @=92H^80-JJP  "3&04 "0              @ $
M97@Q+3$N:'1M4$L! A0#%     @ 0('64LXML1H-#@  BRL   H
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64$L%!@     &  8 :0$  ";G      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
